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SUMMARY 
 
The Kremen1 and Dickkopf1 proteins form an exclusive class (the Dkk class) of 
evolutionarily well conserved antagonists of the canonical WNT/β-catenin pathway. 
Their role is to regulate vertebrate development by maintenance of an important 
constituent, β-catenin at levels desired to perform its necessary function. The proteins 
have been characterised with their respective domain architectures and mutual binding 
has been established in vivo, through co-immunoprecipitation and co-transfection studies. 
The mechanism underlying the binding of the two proteins to further the process of WNT 
inhibition has been intriguing. We have undertaken the crystal structure determination of 
Krm1, Dkk1FL and the Krm1-Dkk1Cys2 complex. 
We have been able to express and purify one of the crucial domains of Dkk1 from 
Mus musculus, proved to be necessary and sufficient in binding with Krm1 and to inhibit 
Wnt signalling. The 78 aa containing C-terminal domain of Dkk1, Dkk1Cys2, has been 
cloned in the pET32a vector and expressed in the E. coli BL21 (DE3) host strain. The 
protein has been purified to homogeneity and is presently under crystallisation trials. 
Krm1 from Mus musculus was cloned into pET32a and found to express completely in 
inclusion bodies in E. coli. Several attempts for expression have failed in both E. coli and 
S. cerevisiae. 
  MeCP2 is another important mammalian protein with a role in the maintenance 
of DNA methylation that is essential for mammalian development. It shares about 70% 
identity with the MBD family of proteins, whose MBD domains are evolutionarily 
conserved. The lack of functional similarity between these proteins outside this domain is 
worth investigation. The structures of the MBD domain from MBD1 and MeCP2 have 
  
  ix 
been determined by NMR and are found to be very similar. However, the pathway that 
MeCP2 chooses for achieving transcriptional repression is still under investigation. 
Additionally, there is a proposed model in the structural context of MeCP2 being 
involved in a medically significant neurological disorder, the Rett syndrome. We attempt 
to address the alteration of its DNA binding function and the above questions by solving 
the structure of full length MeCP2 using X-ray crystallography. 
 MeCP2 from Homo sapiens has been cloned into vectors compatible with E. coli 
and some soluble protein expression has been detected during initial trials. Protein 
expression trials are currently underway for Krm1, Dkk1FL and also for MeCP2 in the 
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CHAPTER 1: INTRODUCTION 
 
1.1 WNT SIGNALLING PATHWAY: BIOLOGICAL BACKGROUND 
The WNT/β-catenin canonical pathway is most extensively studied in cell 
signalling. This pathway involves the evolutionarily conserved secreted WNT (Wingless 
from Drosophila and Int-1 from Mus musculus) cysteine-rich glycoproteins (Clevers, 
2006). About 19 members of the WNT protein family have been identified in mammals 
and the functions of WNTs have been elucidated by genetic and cell biological studies in 
models including Drosophila melanogaster, Danio rerio, Caenorhabditis elegans, 
Xenopus laevis, Musmusculus, sea urchin, chicken embryos and mammalian cultured 
cells (Moon et al., 2002; Moon et al., 2004). They act as short-range ligands that mediate 
signalling through serpentine receptors of the Frizzled gene family. 
WNTs work to regulate a wide range of developmental processes in both embryos 
and adults (Wodarz and Nusse, 1998; Miller et al., 1999; Moon et al., 1997). These 
comprise embryonic induction, generation of cell polarity, cell fate specification, cell 
migration (Cadigan and Nusse, 1997), mammary gland and skin appendage 
morphogenesis and hair follicle formation (Chu et al., 2004). In addition, deregulation in 
WNT signalling that leads to elevated β-catenin levels has been largely implicated in the 
genesis of a number of malignancies (Polakis, 2000; Morin, 1999; Miller et al., 1999; 
Akiyama et al., 2000), degenerative disorders (Nusse, 2005) and several developmental 
defects. 
 WNT genes are not functionally equivalent. They give rise to diverse pleiotropic 
effects through activation of distinct intracellular pathways that abundantly exhibit cross-
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talk with other signalling pathways (Moon et al., 1997). WNT proteins also depend on a 
repertoire of receptors and co-factors present on the cell surface to determine the 
transcriptional endpoints and hence, WNT target genes are mostly cell type specific. In 
particular, three pathways have been identified, namely the WNT/Ca2+ cascade, planar 
cell polarity (PCP) pathway or non-canonical WNT/ β-catenin pathway and the canonical 
WNT/ β-catenin pathway. 
 
1.2 CANONICAL WNT/ β-CATENIN PATHWAY 
Our interest lies in the canonical WNT/β-catenin signalling pathway. WNT signal 
transduction is mediated by the Frizzled (Fz) genes encoding seven transmembrane 
receptor proteins (Vinson et al., 1989; Wang et al., 1996; Chan et al., 1992) with a 
cysteine-rich domain (CRD) at the N-terminus which bind Wnts with high affinity (Hsieh 
et al., 1999). However, the pathway diverges downstream of the Dishevelled protein and 
acts through a core set of highly conserved proteins to regulate β-catenin levels in the 








Figure 1.1. Canonical WNT/β-catenin signalling pathway in (a) absence 
and (b) presence of WNTs, respectively. WNTs bind to Fz and LRP5/6 to 
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induce β-catenin release from the catenin destruction complex and its 
subsequent translocation into the nucleus to activate gene transcription 
(adapted from Moon et al., 2004). 
 
In the absence of active WNT ligands, free cytoplasmic β-catenin is recruited into a     
‘Catenin destruction complex’ assembled by the tumour suppressors, APC and Axin. 
The multiprotein complex, including GSK3β and CK1 triggers phosphorylation of β-
catenin at the N-terminal, leading to ubiquitylation followed by proteosomal degradation 
of β-catenin. This leads to low cytoplasmic and nuclear β-catenin levels, and hence 
inhibition of downstream gene transcriptional events (Moon et al., 2004). 
Activation of the canonical signalling cascade is triggered when secreted WNT 
ligands interact with Fz receptors through the CRD which then bind to the single-pass 
transmembrane protein identified as the low-density lipoprotein receptor related proteins 
5 and 6 (LRP5/6) in vertebrates and Arrow in the Drosophila (Tamai et al., 2000; He et 
al., 2004) at the membrane surface. This results in the inhibition of GSK3β 
phosphorylation of β-catenin by the dissociation of the enzyme from the destruction 
complex (Willert and Nusse, 1998), possibly through the activation of Dsh. In addition, 
Axin is also degraded, further decreasing β-catenin phosphorylation. As a result, the 
stabilised β-catenin then accumulates in the cytoplasm before translocating to the 
nucleus, allowing subsequent complex formation with the DNA bound transcription 
factors, TCF and LEF. These repressed transcription factors activate important target 
genes downstream, leading to a myriad of effects, most notably regulation of cell 
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1.3 ANTAGONISTS OF WNT PATHWAY 
Several antagonists work in concert to dampen the WNT signalling pathway to 
ensure target gene expression in the correct cellular and developmental context. Wnt 
antagonism plays a central role in anterior specification during anteroposterior patterning 
of neural plate during Xenopus gastrulation (Davidson, 2002). Wnt antagonists are of two 
functional classes, the secreted Frizzled-related proteins (sFRP) class and the Dickkopf 
(Dkk) class. Members of sFRP class include sFRP family, WNT inhibitory factor (WIF) 
and Cerberus, exerting their effect by direct binding and sequestration of soluble WNTs   
(Kawano and Kypta, 2003).  
 
1.3.1 Dickkopf-1 protein: significance and characterisation 
Inhibition of WNT signalling can be mediated by the members of the Dickkopf 
(Dkk) family of proteins and in particular, Dkk1 (Glinka et al., 1998). The founding 
member of the multigene Dkk family is Dkk-1, with three other members identified in 
vertebrates, including Dkk-2, Dkk-3 and Dkk-4 (Krupnik et al., 1999; Monaghan et al., 
1999; Niehrs, 2006). Dkks are an evolutionarily ancient gene family, found in 
vertebrates, including humans, and in invertebrates like Dictyostelium, Cnidarians, 
Urochordates and ascidians but not in Drosophila and Coenorhabditis elegans. There is a 
strong functional divergence between Dkk3 and Dkk1/2/4 gene families during early 
metazoan evolution (Niehrs, 2006). Dkk1/2/4, all regulate Wnt Signalling and bind to 
LRP6 and Krm1 and 2 unlike Dkk3 (Mao et al., 2002). 
 Dkks are glycoproteins of 255-350 aa, containing a signal sequence at N-terminus 
and sharing two conserved characteristically spaced cysteine-rich domains. The N-
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terminal cysteine-rich domain, Dkk_N (Cys1) is unique to Dkks and the C-terminal 
cysteine-rich domain (Cys2) has a pattern of 10 cysteines related to colipase fold (Niehrs, 
2006; Aravind and Koonin, 1998). Dkks play an important role in vertebrate 
development, locally inhibiting Wnt regulated processes such as antero-posterior axial 
patterning, limb development, somitogenesis and eye formation. In adults, Dkks are 
implicated in bone formation and bone disease, cancer and Alzhiemer’s disease (Niehrs, 
2006). The characteristic developmental function of Dkk-1 is its head inducing activity 
(Mukhopadhyay et al., 2001; Glinka et al., 1998). A human homologue of Dkk1, Soggy 
(Sk) (Fig. 1.2), has been characterised biochemically and is found to complement Dkk1 















Figure 1.2. Schematic representation of Dkk-1 protein. (a) Dkk-1 
Architecture representing the C1 and C2 domains and percentage identity 
between human and mouse or Xenopus cysteine-rich domains. SP: Signal 
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sequence from human, mouse and Xenopus cysteine-rich domains. 
(adapted from Fedi et al., 1999). 
 
1.3.1.1 Homology of Dkk-1with Colipase family 
The structural and sequence homology between colipase and the C-teminal 
domain of Dkk has been recently discovered (Figs. 1.3 and 1.4). It has been convincingly 
suggested that Dkks and colipases have the same disulfide-bonding pattern and a similar 
fold. The structure of colipase fold is solved using X-ray crystallography and it consists 
of short β-strands connected by loops and stabilised by disulfide bonds, resulting in 
finger-like structures that may serve as interactive surfaces for lipases (Tilbeurgh et al., 
1999).  
 
Figure 1.3. Alignment of the Dkks with colipases and other related 
molecules. Xdkk-1 and Mdkk-1 are the Dkks from Xenopus laevis (XI) 
and Mus musculus (Mm) respectively. COL stands for the colipases. The 
conserved residues are colored according to the 85% consensus rule: polar 
residues, red; acidic and basic residues, pink; hydroxylic residues, blue; 
hydrophobic residues, yellow background; tiny residues, green 
background; small residues, blue backgroud; large residues, gray 
background. The conserved cysteines, which form the disulfide-bonding 
pattern typical of this family, are shown in inverse red shading. The 
disulfide-bonding network connecting the cysteines is shown in a separate 
color for each pair. The predicted structural elements based on the porcine 
colipase crystal structure are shown above the alignment, with arrows 
representing β-strands (adapted from Aravind and Koonin, 1998). 
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The position of the hydrophobic amino acid residues are conserved well between the 
carboxy-teminal domain of Dkk and the colipases. One direct functional implication of 
this observation is that the colipase-like domain of Dkk may be necessary for the 
membrane association of this protein, which in turn may be required for the inhibition of 










Figure 1.4. (a) A three-dimensional model of the colipase fold on the 
basis of the porcine colipase crystal structure. The β-strands are shown in 
yellow, the loops in blue and the disulfide bonds in pink. The hydrophobic 
residues (in the single-letter amino-acid code) are possibly involved in 
lipid interaction, are shown as space-filling spheres in gold (b) Domain 
organisation of the colipase-domain-containing proteins based on 
sequence similarity. Blue: signal peptide; green: N-terminal cysteine-rich 
domain; red: colipase domain; thick bar: 100 amino acids. (adapted from 
Aravind and Koonin, 1998). 
 
1.3.2 Kremen-1: characterisation and biological function 
Kremens are type-I transmembrane proteins, composed of 473aa, Fig. 1.5. There 
are two related forms of Krm (Krm1, Krm2), identified to be widely expressed in adult 
tissues, including the skeletal muscle, brain and during embryonic development. It 
consists of three conserved extracellular domains, namely the kringle domain, Wsc and 
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CUB (Complement Sub components Clr/Cls, Ugef, Bmp1), while the intracellular region 
has no conserved motif involved in signal transduction (Nakamura et al., 2001). 
 Kringles are autonomous structural domains found predominantly in blood 
clotting and fibrinolytic proteins and in some serine proteases. They are believed to play 
a role in binding mediators such as membrane phospholipids and proteoglycans. The Wsc 
domains are present in yeast cell wall integrity and stress response component proteins. 
The CUB domain is involved in protein-protein and glycosaminoglycan-protein 
interactions, and in a number of proteins involved in development and differentiation. 
Although amino acid sequence homologies between vertebrate Krm1 and Krm2 are only 
about 35-40%, their occurrence and the order of their domains are conserved in all 
orthologues (Davidson et al., 2002). A potential role of Kremen is seen in the regulation 
of cellular responses upon external stimulus or cell-cell interaction in neuronal and/or 
muscle cells (Nakamura et al., 2001). Krm is expressed maternally in mouse and frog in 
the early anterior neural folds. Both Krm1 and Krm2 are co-expressed with Dkk1 in the 
prechordal plate underlying the anterior neurectoderm. These expression domains are 
consistent with a role of Krm in regulating early anteroposterior (AP) patterning in CNS 
and in Wnt inhibition pathway (Davidson, 2002). 
 
1.4      WNT ANTAGONISTS IN ACTION: INTERACTION OF DKK-
1/KRM/LRP5/6 
Physiological interaction between Krm and Dkk1 proteins in vivo has been 
studied in Xenopus laevis. Kremens bind both Dkk1 and Dkk2 (but not Dkk3) with an 
apparent Kd in the nM range. It has been shown that both Krm and Dkk1 are required 
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equally to block Wnt/LRP Signalling (Davidson, 2002). The membrane attachment of 
Krm proteins via GPI-anchor is important for mediating the Wnt/LRP inhibition of Dkk1. 
All the three ECDs (Kringle, Wsc and CUB domains) of Krm1 are required for binding 
with Dkk1, as proved by the co-immunoprecipitation and co-transfection assays carried 
out with the ECD deletion constructs of Krm1 and alkaline phosphatase fused Dkk-1 (Fig 
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 Figure 1.5. Sequence comparison of Krm proteins. (a) Alignment of 
Krm1 and Krm2 protein sequences from Xenopus (X) and mouse (m).The 
Kringle, Wsc and CUB and transmembrane domains are highlighted and 
conserved amino acids are shown in white (within coloured domains) or 
red. (b) Krm homology tree and matrix showing overview of homology 
and amino acid identity, respectively, between the Xenopus, mouse and 
human Krm proteins. (adapted from Davidson et al., 2002). 
 
Dkk1 is a high-affinity ligand for LRP5/6 and binds both LRP5 and LRP6 and at 
an apparent Kd in the range 10-10 M (Bafico et al., 2001; Mao et al., 2001; Semenov et al., 
2001). The Dkk1/LRP5/6 complex subsequently binds to Kremen (Krm1/2) (Mao et al., 
2002). Formation of this ternary complex triggers rapid endocytosis and the consequent 
removal of LRP5/6 from the plasma membrane, preventing the WNT signalling and β-
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Figure 1.6. Deletion analysis of Kremen and Dickkopf. (a) Schematic 
drawing of (left) mkrm2 and (right) Dkk-1 deletion constructs. SP, signal 
peptide; KR, kringle domain; TM, transmembrane domain; L1, L2, linker 
region 1, 2 (b) Summary of the binding and Wnt inhibition of the mkrm2 
deletion constructs (c) Bound AP activity measurement colorimetrically at 
405nm (left) Dkk1–AP binding to 293T cells transfected with mkrm2 
deletion constructs; (right) 293T cells transfected with LRP6 or mkrm2 as 
indicated, incubated with recombinant XDkk1-AP, AP-XDkk1-Cys1, or 
AP-XDkk1-Cys2 respectively (adapted from Mao et al., 2002; Mao and 
Niehrs, 2003). 
 
The colipase fold of Dkk1 (Cys2) is necessary and sufficient for Kremen and LRP6 
binding and for Wnt inhibition, shown by AP- bound deletion analysis of Dkk-1 (Fig 1.6) 










Figure 1.7. A model showing the functional interactions of Dkk1, LRP5/6 
and Krm to block the Canonical Wnt signal in cells (adapted from Mao et 
al., 2002). 
 
1.5 DNA METHYLATION 
DNA methylation, mainly at the sequence of CG, is the most common covalent 
epigenetic modification of the eukaryotic genome, involving the addition of a methyl 
group at position-5 of cytosine in cytidine-guanosine (CpG) dinucleotide pairs. Roughly, 
70% of all CpG dinucleotides in the mammalian genome are methylated and majority of 
these sites occur in repetitive DNA elements. CpG islands are genomic regions that 
contain a high frequency of CG dinucleotides. They are in and near approximately 40% 
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of promoters of mammalian genes. Unlike CpG sites in the coding region of a gene, in 
most instances, the CpG sites in the CpG islands of promoters are unmethylated if genes 
are expressed.  
Methylation of CpG sequences has been implicated in stable modulation of cell-
type specific gene expression during development by affecting the protein-DNA 
interactions that are required for transcription (Cedar, 1988). Examples include gene 
silencing observed in inactive X-chromosome and other chromosomal abnormalities 
(Riggs and Pfeifer, 1992), in genomic imprinting (Bartolomei and Tilghman, 1997; 
Neumann and Barlow, 1996; Razin and Cedar, 1994), in transformed cell-lines and 
tumors (Bird, 1996; Rountree et al., 2001). 
 
1.5.1 Methyl-CpG binding proteins (MeCP2) 
Methyl-CpG binding proteins form a family of five proteins, including MBD1, 
MBD2, MBD3 and MBD4 (Hendrich and Bird, 1998; Wade, 2001), that bind methylated 
CpG (mCpG) sequences within double-stranded DNA and represses transcription by 
recruiting histone deacetylases (Nan et al., 1998; Jones et al., 1998; Ballestar and Wolffe, 
2001). Each member of this family has a stretch of 60-80 amino acid residues displaying 
50-70% similarity between all five proteins. MBDs interact with transcriptional 
repressors and chromatin remodeling factors (Bird et al., 2002; Kimura and Shiota, 
2003). 
 The MBD of MBD4 is most similar to that of MeCP2 in primary sequence, while 
the MBDs of MBD1, 2 and 3 are more similar to each other than to either MBD4 or 
MeCP2 (Figs. 1.8 and 1.9). The presence of an intron, located at a conserved position in 
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all genes (Hendrich and Bird, 1998), indicates that the MBDs within each protein are 
evolutionarily related, but the lack of similarity between these proteins outside of the 
MBD (excluding MBD2 and MBD3) may indicate that each protein carries out a 
different function within the cell (Hendrich and Bird, 1998). 
 
Figure 1.8. Domain organisation of MBD family members. For each 
protein, the MBD domain is depicted as a green box, the TRD domain as 
yellow box, CXXC repeats of MBD1 as blue box, GR repeat of MBD2 as 
purple box and acidic repeat at the carboxy terminus as orange box 
(adapted from Wade, 2001). 
 
1.5.2 Structure of MBDs 
The alignment of MBD proteins from selected organisms is given in Fig. 1.9. 
Ohki et al., (1999) determined the structure of MBD of the human methylation-dependent 
repressor MBD1, while Wakefield et al., (1999) determined the structure of MBD of 
MeCP2 using NMR, Fig. 1.10. Although the sequences from MBD1 and MeCP2 exhibit 
only a moderate degree of homology, sequences can easily be aligned with a number of 
conserved residues throughout the MBD. The structures of the two MBDs are very 
similar. 
The structure is a novel-wedge shaped α/β sandwich. The four up and down 
antiparallel β-sheet is contributed by NH2 terminal constituting one face of the wedge, 
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(highly positively charged) (Wakefield et al, 1999). Another face of the wedge is formed 
by the three-turn helix with another single turn helix in the COOH terminal of the protein 














Figure 1.9. Sequence alignment of the MBD family proteins. Conserved 
residues are boxed. Important residues are colored (blue, basic; yellow, 
hydrophobic; green, acidic or polar (adapted from Ohki et al., 1999). 
 
            a                                                  b 
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Figure 1.10. (a) Solution structure of the MBD of MBD1 (adapted from 
Koradi et al., 1996). (b) Putative DNA binding site of MBD. Basic 
residues are colored in blue; aromatic residues, yellow; an acidic residue, 
green. Main chains of residues strongly affected by addition of methyl-
CpG DNA are colored in red. B-form DNA is also shown in the left-hand 
figure, with methyl groups in the symmetric methyl-CpG highlighted in 
yellow (adapted from Ohki et al., 1999). 
 
MBDs do not undergo dimerisation for recognition of symmetrical mCpG 
sequences, but bind to DNA as monomer (Nan et al., 1993). Mutation analysis on MBD 
has resulted in a putative model of MBD with DNA, Fig. 1.10 (b) (Ohki et al., 1999). The 
model proposes that the interaction between MBD and methylated DNA takes place 
along the major groove of a standard B-form DNA. The two longer β-sheet strands (β2 
and β3), as well as the loop between them (L1), would interact with the major groove of 
the DNA. Also, the residues between β4 and α1 seem to establish contacts with the 
phosphate backbone. MBDs from other proteins are likely to contain a similar fold, 
although MBD1, MBD2 and MBD3 must exhibit local differences in structure, 
particularly at the thick end of the wedge-shaped domain. 
 
1.5.3 MeCP2 
 MeCP2 is found to be essential for embryonic development and contributes to 
methylation-dependent gene silencing (Li et al., 1993; Bird, 1993; Tate and Bird, 1993; 
Meehan et al., 1989; Boyes and Bird, 1991; Lewis et al., 1992; Nan et al., 1997). MeCP2 
is concentrated on the pericentromeric heterochromatin in the genome (Lewis et al., 
1992; Nan et al., 1996). Species and tissue comparisons show that MeCP2 is widely 
distributed in mammals except in embryonal carcinoma cell lines, which have very low 
levels (Meehan et al., 1989). 
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1.5.4 Architecture of MeCP2 
MeCP2 is an archetypical methyl-CpG-binding and multidomain protein, 
containing the domains: Methyl-CpG binding domain, MBD (residues 77-162), Co-
repressor interacting domain, CRID (163-207 aa), transcriptional repression domain, 
TRD (208-311 aa) and His-Pro domain (312-404 aa). It has the first methyl CpG-binding 
domain (MBD) protein to be identified that is involved in selective recognition of CpG 
(Wade, 2001; Lewis et al., 1992; Nan et al., 1993). The protein localises to densely 
methylated regions (major satellite DNA) in the mouse genome (Wade, 2001; Nan et al., 
1996). The TRD overlaps a nuclear localisation signal (Wade, 2001; Nan et al., 1997). 
The region upstream to the MBD has no known function. The carboxyl terminus of 
MeCP2 has unusual and repetitive sequences that are similar to members of the fork head 
family (Wade, 2001; Vacca et al., 2001). 
MeCP2 binds to single, symmetrically methylated CpG dinucleotide at 
hemimethylated or fully methylated DNA sites on the chromosome regardless of 
sequence context (Nan et al., 1996; Lewis et al., 1992). However, the former is a poor 
substrate. The methyl group and base identity is important for MeCP2 binding. AT-rich 
DNA containing methyl CpG is a preferred substrate for MeCP2 (Meehan et al., 1992; 
Klose et al., 2005).  
 
1.5.5 Role of MeCP2 in transcription repression 
A major breakthrough in the study of MeCP2 dependent repression came with the 
finding that MeCP2 binds to a methylated DNA and recruits the Sin3–histone deacetylase 
complex to promoters, resulting in deacetylation of core histones and subsequent 
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transcriptional silencing. The region of interaction with Sin3 on MeCP2 significantly 
overlapped the TRD domain (Jones et al., 1998; Nan et al., 1998; Wade, 2001). MeCP2 
possibly utilises multiple pathways to achieve a repressed state (Fig. 1.11). Presumably, 
the choice of mechanism is influenced by the cell type, DNA sequence and local 
chromatin architecture (Wade, 2001). 
 
       
     
 
Figure 1.11. Proposed potential mechanisms for repression mediated by 
MBD proteins. In the cartoons, histone octamers are represented by gray 
balls and DNA is in blue. (a) Model 1- MBD proteins interact with 
HDAC to generate hypoacetylated, condensed chromatin (b) Model 2- 
MBD proteins coat methylated loci occluding regulatory DNA (c) Model 
3- MBD proteins alter local DNA and or chromatin architecture (d) Model 
4- MBD protein sequesters an essential transcription factor,  preventing its 
function (adapted from Wade, 2001). 
 
It has been demonstrated, in vitro and in vivo in mammalian cells that MeCP2 directly 
prevents a component in the basal transcription machinery from functioning, probably by 
direct contact of one of its domains (TRD with TFIIB) during the assembly of pre-
initiation complex. It represses transcription at a distance of greater than 500 bp from the 
transcription site and selectively inhibits transcription complex assembly on methylated 
DNA (Kaludov et al., 2000). TRD actively represses transcription from both 
 a. Model 1 
 b. Model 2 
c. Model 3 
d. Model 4 
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unmethylated and methylated promoters, relying significantly on histone deacetylation 
(Nakao et al., 2001; Nan et al., 1998). 
 
1.5.6 MeCP2 and Rett Syndrome 
MeCP2 also participates in epigenetic control of neuronal function (Amir et al., 
1999). About 80% of the classic Rett syndrome, a neuro-developmental disorder, is 
caused by mutations occuring denovo during spermatogenesis, which leads to X 
chromosome inactivation (Xq28) (Van den Veyver et al., 2001). Although MeCP2 is 
ubiquitously expressed, the phenotype of the syndrome is restricted to the brain (Roloff et 
al., 2003). In females, Rett syndrome is one of the most common causes of mental 
retardation with an incidence of one in 10000-15000 (Hagberg, 1985). Most missense 
mutations seem to interfere with the normal function of MBD or TRD, majority of the 
truncating mutations delete at least a part of the TRD. This leads to partial or complete 
loss of protein function, especially involved in brain development (van den Veyver et al., 
2001; Chen et al., 2001). R106W, R133C, F155S and T158M are mutations at the 
methyl-CpG binding domain (MBD), which impair binding affinity to methylated DNA 
(Ballestar et al., 2000). 
 
1.6 STRUCTURE DETERMINATION OF PROTEINS 
Proteins, an important class of biological macromolecules present in all living 
organisms, perform their functions by folding into specific spatial conformations. The 
function of a protein at the molecular level is clearly understood by determining its three 
dimensional structure by techniques such as X-ray crystallography, Nuclear Magnetic 
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Resonance (NMR) spectroscopy and cyro-electron microscopy. Each technique has its 
own strengths and limitations and complements each other in structure determination. 
 
1.6.1 History and application of macromolecular X-ray crystallography 
X-rays were discovered in 1895 by Wilhelm Röntgen. In 1912, the longitudinal 
nature of X-rays was proved to the scientific community, when German physicist Max 
von Laue directed an X-ray beam through a crystal and observed an interference or 
diffraction pattern. In 1915, W.H. Bragg and W.L. Bragg won the Nobel Prize for 
Physics, for the formulation of X-ray crystallography. They proved that the structure of a 
crystal on the molecular level could be deduced from the study of an interference pattern. 
In the past 40 years, this important discovery has gained such a high momentum, that 
nearly 35,000 protein structures have been determined using this technique. However, 
this number represents only a small part in the entire congregation of proteins known and 
unknown to the scientists worldwide. 
 
1.6.2 Protein crystallisation 
Crystallisation is one of the several means (including nonspecific aggregation / 
precipitation) by which a metastable supersaturated solution can reach a stable lower 
energy state by reduction of solute concentration (Weber, 1991). The three stages of 
crystallisation common to all molecules are nucleation, growth, and cessation of growth. 
Nucleation is the process by which non crystalline aggregates that are free in solution, 
come together to produce a thermodynamically stable aggregates with a repeating lattice, 
which must first exceed a specific size (the critical size) to become a supercritical nucleus 
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capable of further growth. The degree at which nucleation occurs is determined by the 
degree of supersaturation of the solutes in the solution. The critical size is dictated by 
several operating conditions like temperature, supersaturation, pH, ionic strength etc. 
The most commonly used methods for crystallisation are the hanging drop and 
sitting drop vapor-diffusion methods, dialysis and batch method. The hanging and sitting 
drop methods rely on the diffusion of a precipitant / volatile agent between a micro-drop 
of mother liquor and much larger reservoir solution. The principle behind initial 
crystallisation trials is the application of the Sparse matrix method. This method allows 
for quick screening of several conditions like wide ranges of pH, salts, precipitants and 
additives / ligands that are selected from known crystallisation conditions. After 
obtaining small crystals, that particular condition(s) could be optimised further to obtain 
crystals of suitable size and quality for diffraction experiments. 
 
1.7 BASIC CONCEPTS IN PROTEIN CRYSTALLOGRAPHY 
Crystals are defined as solids with a periodic three dimensional arrangement of an 
atomic structure. The simplest repeating unit in a crystal is called a unit-cell with three 
basis vectors a, b and c, and inter-axial angles α, β and γ between them (Fig. 1.12). The 
smallest and unique volume within the unit-cell that can be rotated and translated to 
generate one unit-cell is called the asymmetric unit. 
Unit-cells are classified into seven different systems based on their dimensions. 
The arrangement of molecules in a unit-cell is governed by symmetry (Section 1.7.1) and 
this symmetrical arrangement defines the system of that crystal. Table 1.1 shows the 7 
different crystal systems: 
  





Figure 1.12. The unit-cell 
 
1.7.1 Lattices, point groups and space groups 
In a crystal, unit-cells are arranged in a contiguous way to fill space. If a point is 
assumed to represent a whole unit-cell, then the array of all points will form a lattice. 
Table 1.1 summarises the collection of 14 such lattices, known as Bravais lattices. The 
Bravais lattices are classified as primitive, P (simple unit-cell with one point for each 
unit-cell), face centered, F (an additional lattice point at the center of each face), body 
centered, I (an additional point at the center of the cell), end centered, C (an additional 
point at the center of one face). 
Molecules are arranged in the unit-cell with certain symmetry operations when 
packed into a crystal. A symmetry operation gives an identical or similar image of an 
object. Besides unit translations along the three unit-cell axes, called three-dimensional 
translation symmetry, the three crystallographic symmetry elements are rotation, 
reflection, and inversion. The combination of these symmetry elements that acts on a 
unit-cell is commonly called a point group. There are totally 32 crystallographic point 
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Rotation or reflection, when combined with translation, will generate screw or glide 
symmetry, respectively. The combination of lattices and point groups leads to 230 
different possible ways of molecular packing in a crystal, known as space groups, out of 
which, only 65 space groups are applicable to protein crystals (McRee, 1999). 
 
1.7.2 hkl plane 
The diffraction effect of a crystal (Section 1.7.3), is well explained using the 
concept of hkl planes. When X-rays are diffracted by a crystal, each resulting spot is 
created by an imaginary set of parallel ‘hkl’ planes that slice the entire crystal in a 
particular direction. The index h is the number of integral parts into which the set of 
planes cuts the X direction (or a-axis) of each unit-cell. Similarly, the indices k and l 
specify how many such planes exist per unit-cell in the Y and Z directions. The family of 
planes having indices hkl (h, k, l must be integers) is the hkl family of planes. 
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1.7.3 Principle of X-ray diffraction and Bragg’s law 
 X-rays are electromagnetic waves which interact with matter like electrons. X-
rays, scattered from different electrons, will travel different distances, differing in their 
relative phases. Thus, there will be interference when they are in phase (constructive 
interference) or when out of phase (destructive interference), Fig. 1.13. 





Figure 1.13. (a) Constructive interference (b) destructive interference 
 
The geometric requirements needed for diffraction to occur were first explained by 
Bragg. Bragg showed that a set of parallel planes, n, with indices, hkl and interplanar 
spacing, dhkl produces a diffracted beam when X-rays of wavelength λ impinge on the 
planes at an angle θ and are reflected at the same angle, only if θ meets the condition 






Figure 1.14. Bragg’s law. 
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This is known as Bragg's law for X-ray diffraction, Fig. 1.14. 
 
1.7.4 Reciprocal space 
A reciprocal lattice is defined as a discrete set of diffracted rays whose vectors are 






Figure 1.15. Reciprocal lattice. 
In Fig. 1.15, the Bragg planes and the incoming and reflected rays are shown, as before, for 
two diffraction angles, but now a vector perpendicular to the Bragg plane is added for each. 
The phase of a wave diffracting from an object lying in between two Bragg’s planes depends 
on the fraction of the distance of the object from one Bragg plane to the next. If the position 
of the object is considered as a vector, then the distance of that object from one of the Bragg 
planes can be obtained by projecting that vector on the plane normal. The phase shift can 
then be obtained by dividing the projected distance by the Bragg spacing between the planes. 
Mathematically, we can carry out the projection and division by giving the plane normal a 
length equal to the reciprocal of the Bragg spacing, and then computing the dot product 
between the position vector and the plane normal. Because the plane normal is a vector with 
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1.7.5 The Ewald sphere 
Ewald’s geometrical construction, Fig. 1.16, helps us visualise which Bragg 






Figure 1.16. The Ewald sphere. 
Rearranging Bragg’s law in reciprocal space, 
       (Eq. 1.2) 
Fig. 1.16 demonstrates how each reciprocal lattice point must be arranged with respect to 
the X-ray beam in order to satisfy Bragg’s law and produce a reflection from the crystal. 
Since the Ewald sphere is three dimensional, reflections by hkl planes when exposed to 
X-rays form a three dimensional network of diffraction spots. If the Ewald sphere has a 
diameter of 2/λ, then any reciprocal-lattice point within a distance 2/λ from the origin can 
be rotated into contact with the sphere to form a diffraction spot. 
 
1.7.6 Fourier transformation and structure factor equation 
  The atomic arrangement (or electron density) in a crystal is related to all the 
diffraction spots that are obtained from a crystal through the Fourier transformation 
principle. The electron density at any point can be calculated using Eq. 1.3. 
  





zyx ++−∑∑∑= πρ    (Eq. 1.3) 
In the above equation, we are transforming the reciprocal space of lattice planes to 
real or direct space electron density at the point x,y,z. Thus, if we know Fhkl, the structure 
factor (inverse space entity from diffraction by electrons), we can calculate the actual real 
structure (the density of electrons in real space). 
The Structure factor Fhkl for a reflection h,k,l is a complex number derived quite 











     (Eq. 1.4) 
This is a simple summation, which extends over all atoms j at  fractional coordinates xj, yj 
and zj and f(j) is the scattering factor of each atom which depends on the atomic number 
of that atom and the diffraction angle of the corresponding reflection (h,k,l). Ironically, 
Eq. 1.4 shows that if we know the positions of all atoms (the structure) then we can easily 
calculate all structure factors and with the help of Eq. 1.3, we can calculate the electron 
density at any point (again, the structure). 
 
1.7.7 Phase problem 
In order to compute Eq. 1.4, we need the amplitudes of all diffracted waves 
(involving the scattering factor component), which are obtained from the intensities of 
the diffraction spots and also their relative phase shifts with respect to the origin of the 
unit-cell (involving the positions of all atoms), which cannot be measured directly. The 
immeasurability of the phase angle is known as phase problem. 
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The structure factor equation, Eq. 1.4, can be rearranged as shown in Eq. 1.5 to 








])(2sin)(2[cos||)( ππ   (Eq. 1.5) 
The methods used for phase angle estimation are discussed in the next section. Solving 
the phase problem is the most crucial step in crystal structure determination. 
 
1.8 STRUCTURE DETERMINATION 
1.8.1 Solution to phase problem 
Four methods are used to solve the phase problem in macromolecular structure 
determination. They are: direct methods, heavy-atom method (or isomorphous 
replacement method), anomalous scattering method (also called anomalous dispersion) 
and molecular replacement method. All these methods only yield phase estimates for a 
limited set of reflections. To improve the accuracy of the phase and to get an interpretable 
electron density map, refinement at both reciprocal and real space is carried out with the help 
of Fourier transformation. 
 
1.8.2 Direct methods 
This method relies on the possibility of development of useful statistical 
relationships between sets of structure factors to deduce their phases. However, we must 
assume a crystal to be made up of similarly-shaped atoms with positive electron density 
everywhere. The direct methods estimate the initial phases for a selected set of reflections 
using a triple relation and extend phases to more reflections. A triple relation is one in 
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which there are trio of reflections in which the intensity and phase of one reflection can 
be explained by the other two.  
The prime requirement for the direct methods to be successful in protein 
crystallography is very high resolution data (> 1.2 Å). This has limited its usefulness as 
only structures of small molecules can be solved easily, although the direct methods have 
been used to phase proteins up to 1000 atoms. 
 
1.8.3 Molecular replacement (MR) 
The molecular replacement method is used when a protein molecule has high 
sequence and hence structural similarity to an already solved protein structure (referred to 
as the search model). Usually, the Patterson function (a function derived using structure 
factors) of the search model is first correctly orientated in the new crystal unit-cell by 
means of rotation functions and then translated to achieve the best fit that is supported by 
a convincing correlation factor and a residual factor (details of the residual factor in 
section 1.8.7). 
 
1.8.4 Multiple isomorphous replacement (MIR) 
In this technique, first an X-ray data set for a protein crystal (native crystal) is 
collected. Following this, the native crystal is soaked in a specific heavy atom, such as 
mercury, platinum or gold. The goal is to obtain derivative crystals in which heavy atoms 
bind specifically and consistently to each protein molecule in the unit-cell. Another data 
set is collected for the derivative and the positions of the heavy atoms are determined 
using difference Patterson maps. Once the initial heavy atom locations have been 
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determined, the coordinates, occupancy and temperature factors of each heavy atom are 
refined. At least two isomorphous derivatives (which are essentially isomorphous to the 
native crystal) are needed for successful structure determination by MIR. 
 
1.8.5 Anomalous scattering 
The atomic scattering factor of an atom has three components as shown in Eq. 
1.6.   
                                       f = f0+ f ′+ if ″           (Eq. 1.6) 
f0 is a scattering term that is dependent on the Bragg angle and the two terms f′ and f″ are 
independent of the scattering angle, but dependent on wavelengths. These latter two 
terms represent the anomalous scattering that occurs at the absorption edge when the X-
ray photon energy is sufficient to promote an electron from an inner shell to the next 
shell. The dispersive term f′ reduces f0 whereas the absorption term f″ is 90° advanced in 
phase with respect to f′. This leads to a breakdown in Friedel's law (which in a normal 
case gives Fhkl = F-h-k-l), giving rise to anomalous differences that can be used to locate 
anomalous scatterers in a crystal, if any. 
 
1.8.5.1 MAD 
Isomorphous replacement has several problems: non-isomorphism between 
crystals (unit-cell changes, reorientation of the protein, conformational changes, changes 
in salt and solvent ions), problems in locating all the heavy atoms, problems in refining 
heavy-atom positions, occupancies and thermal parameters and errors in intensity 
measurements. The use of the multiwavelength anomalous dispersion (MAD) method 
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overcomes the non-isomorphism problems. The method used is similar to MIR in the 
calculation of difference Patterson maps to locate anomalous scatterers but now, we 
calculate difference anomalous Patterson maps. 
Data are collected at several, typically three, wavelengths in order to maximise 
the absorption and dispersive effects. The method demands excellent optics for accurate 
wavelength setting with minimum wavelength dispersion. Generally, all data are 
collected from a single frozen crystal with high redundancy in order to increase the 
statistical significance of the measurements and data are collected with as high a 
completeness as possible. 
 
1.8.5.2 SAD 
Single anomalous dispersion (SAD) is a sub-set of MAD. It is becoming 
increasingly practical to collect data at the absorption peak and use density-modification 
protocols to break the phase ambiguity and provide interpretable maps. 
 
1.8.6 Phase improvement 
The experimentally determined phases are usually not accurate enough to give a 
completely interpretable electron-density map. Thus, a variety of phase improvement 
techniques are available, like density modification, solvent flattening, histogram 
matching and non-crystallographic averaging to modify electron density and improve 
phases. Solvent flattening is a powerful noise suppression technique that removes 
negative electron density and sets the value of electron density in the solvent regions to a 
value lower than that of protein electron density. Histogram matching alters the values of 
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electron-density points to concur with an expected distribution of electron-density values. 
Non-crystallographic symmetry averaging imposes equivalence on electron density 
values when more than one copy of a molecule is present in the asymmetric unit. Density 
modification is a cyclic procedure, involving back-transformation of the modified 
electron-density map to give modified phases, recombination of these phases with the 
experimental phases and calculation of a new map which is then modified iteratively until 
convergence. 
 
1.8.7 Model building and refinement 
A model of the subject protein is produced by fitting the components of the 
structure into the experimentally derived electron-density map, followed by refinement. 
Generation of an atomic model of the molecule(s) is a crucial step in the structure 
determination process. The model-building task may be far from straightforward because 
of poor phase information and the resolution of the diffraction data may be limited. 
However, automation in the recent years has enormously reduced the amount of time 
involved in manual model building.  
When an initial atomic model is available, a vast amount of geometrical restraints 
of the structure can be applied in the structure refinement and rebuilding process, in order 
to generate better phases and in turn, a better / accurate atomic model. These steps are 
carried out in an iterative way to achieve gradual improvement of the model. Refinement 
of a model is the optimisation of a function of a set of observations by changing selected 
associated parameters so that the atomic model agrees well with the diffraction data. 
Refinement programs refine the geometry and temperature factors of the model atoms to 
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improve the fitness of observed and calculated structure-factor amplitudes. Low-
resolution data must be collected for proper evaluation of the structure because this is 
used in bulk solvent averaging. The highest possible resolution limit should be used 
because this maximises the accuracy and precision of the structure. This is determined by 
the signal-to-noise ratio [I/σ(I)], completeness and redundancy of data within the highest 
resolution shell. After several rounds of refinement and map fitting, the model is 
considered as an acceptable final model. The refinement of the structural model against 
the experimentally observed X-ray diffraction data is measured by a ‘residual’ or 
‘reliability’ factor (R-factor), Eq. 1.7. The progress in iterative real and reciprocal space 
refinement is monitored by computing the difference between the measured structure 
factor |Fobs| and the calculated structure factor |Fcalc| from the current model. 
    (Eq. 1.7) 
When the model converges to a correct structure, the difference between measured F's 
and calculated F's will also converge. A desirable target R factor for a protein model 
should be less than 0.25. 
 
1.8.8 Validation and structure deposition 
The correctness and precision of atomic parameters in a structure will need to be 
assessed thoroughly, both during and after refinement. Validation of the correctness of the 
model of a macromolecule obtained from crystal structure analysis is necessary for several 
reasons. The number of atoms in the model and therefore the number of refined parameters 
may not be significantly higher than the number of measured unique reflections, especially at 
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low resolution. Moreover, a large percentage of reflection intensities may be rather weak in 
relation to their estimated uncertainties. In addition, some parts of the model are usually more 
flexible or disordered and their conformation cannot be confidently defined in an electron-
density map. When the model is refined without restraints, even at atomic resolution, these 
weakly defined regions of the model become very disordered, in contrast to well defined 
fragments (Dauter et al., 1992; Kleywegt, 2000). As long as both the R and Rfree (calculated 
with about 10% of relections that are not included for refinement) values continue to 
decrease with each cycle of refinement, the process is repeated and an improved protein 
structure model can be built. Furthermore, as torsion angles are usually not restrained during 
refinement, their agreement with expected values in the Ramachandran plot (Ramachandran 
et al., 1963; Ramakrishnan & Ramachandran, 1965) and proper side chain rotamers are 
extremely useful in model validation. 
Once an X-ray structure for a macromolecule is determined and it has 
successfully passed a proper validation process, the resulting model is deposited in the 
Protein Data Bank (PDB) (http://www.rcsb.org/pdb) and is available to the world. 
 
1.9 OBJECTIVES OF THE PROJECTS 
Kremen1, Dickkopf1 and MeCP2 are highly evolutionarily conserved proteins, 
each playing a very significant and crucial role in the development of mammals. 
Krm1 and Dkk1 are in vivo binding partners which specifically inhibit the 
passage of Wnt signal through cells, by forming a ternary complex with another protein 
LRP5/6 on cell membrane. Internalisation of the` complex from the membrane is 
triggered by Dkk1. The binding sites for Dkk1 with both Krm1 and LRP5/6 locate to the 
C-terminal cysteine rich domain, Dkk1Cys2. However, binding of Krm1 to Dkk1 
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requires the presence of the entire extracellular domain. Structure determination of the 
involved proteins, especially, Dkk1, poses special interest, as it is an important 
therapeutic target, specifically for osteoporosis and cancers. Thus, our aim is to 
understand the mechanism of Wnt inhibition by solving the protein structures 
individually (Krm1 and Dkk1FL) and also as a complex (Krm1-Dkk1Cys2). 
MeCP2, belonging to MBD family of proteins, is a key player involved in the 
prime function of DNA methylation and transcriptional repression in mammals. MeCP2 
and its role in regulating the transcriptional machinery have been under scrutiny for the 
past 10 years. Although there are solved structures of MBD from MBD1 and MeCP2 
available, none of them strongly suggest the exact mechanism of MeCP2 in transcription 
inhibition and the Rett syndrome. We attempt to address this problem by solving the 
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1 PREPARATION FOR TARGET GENE AMPLICATIONS 
2.1.1 Generation of cDNA using RT-PCR 
Total mRNA was extracted from an embryonic day (E) 14.5 mouse embryo using 
Trizol (Invitrogen) and the RNEasy (Qiagen) kit. RT-PCR was carried out according to 
the Superscript® III First Strand Synthesis system for RT-PCR protocol (Invitrogen). An 
RNA / primer mix was prepared as: 1 μl of dNTP mix (10 mM), 1 μl of oligo(dT)20 (50 
μM) and 1 μl of total RNA (1.6 μg) obtained previously from a mouse embryo were 
combined in a 0.2 ml eppendorf tube and made up to a total volume of 10 μl with DEPC-
treated water. RNA was denatured by incubation of the primer mixture in the heat block 
at 65 °C for 5 min, before placing on ice for 1 min. A 10 μl cDNA synthesis mix was 
prepared by addition of the components in the order: 2 μl of 10X RT Buffer, 4 μl of 25 
mM MgCl2, 2 μl of 0.1 M DTT, 1 μl of 40 U/μl RNase OUT™, 1 μl of 200 U/μl 
Superscript™ III RT. RNase OUT™ recombinant RNase inhibitor was included to 
minimise the degradation of RNA due to possible ribonuclease contamination. 
The cDNA synthesis mix was combined with the cooled RNA primer mixture and 
incubated at 50 ˚C for 50 min. The cDNA synthesis reaction was then terminated at 85 ˚C 
for 5 min, before replacing it back on ice. This was followed by adding 1 μl of RNase H 
and further incubation at 37 ˚C for 20 min. RNase H was used for improved sensitivity of 
the next PCR step by removal of the RNA template. The newly synthesised cDNA was 
stored at -20 ˚C until further use for PCR. 
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2.1.2 Primer design for PCR 
Primers were designed for PCR of the following genes: 
1. 21-353 aa fragment containing the extracellular domain of Kremen1 (Mus 
musculus) 
2. 1-272 aa, full length Dickkopf1 (Mus musculus) 
3. 195-273 aa fragment containing the cysteine-rich domain 2 of Dickkopf1 (Mus 
musculus) 
4. 1-487 aa, full length MeCP2 (human Sezary-4 lymphoma cell line) 
The upstream and downstream oligonucleotide primers were incorporated with 
flanking restriction sites that was present in the multiple cloning site (MCS) of the 
corresponding vector that was used for subcloning and absent in the insert to be cloned. 
 
2.2 PCR OPTIMISATION PROCEDURE 
2.2.1 Kremen1 
Gradient PCR was first performed using an Eppendorf® Mastercycler Personal 
PCR machine to optimise the annealing temperature across a broad range (55-67 °C) 
using a set of forward and reverse oligonucleotide primers with respective RE sites 
flanking the primer ends. A 50 µl PCR reaction mixture was prepared for amplifying 
Kremen1 containing 25 µl of 2X ImmoMix™ (BioLine), 1 µl each of 10 µM upstream 
and downstream oligonucleotide primers, 2 µl of cDNA as DNA template.  
A two-step gradient program was designed to amplify the insert with a 30 cycles 
PCR reaction. The first step involved 10 cycles of denaturation at 94 ˚C for 30 sec, 
annealing at 58 ˚C for 1 min, extension at 72 ˚C for 1 min, followed by another 
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elongation at 72 ˚C for 3 min. The second step involved 20 cycles of denaturation at 94 
˚C for 30 sec, annealing at 66 ˚C for 1 min, extension at 72 ˚C for 1 min, followed by a 
final elongation at 72 ˚C for 5 min. 
 
2.2.2 Dickkopf1 (Dkk1 FL and Dkk1 Cys2) and MeCP2 
A 50 µl reaction mix containing 1 µl of upstream and downstream primers 
respectively (10 µM), 2.5 µl of 10X Mg-free buffer, 1.5 µl of MgCl2, 1 µl of dNTP mix, 
0.5 µl of Expand High fidelity DNA polymerase (Roche) was used. The template used 
for Dkk1 FL, Dkk1 Cys2 and MeCP2 was the pGEM-T-Easy clones containing the 
respective full length inserts. 
Touchup PCR was used to amplify Dkk1FL, Dkk1Cys2 and MeCP2. The 
amplification was performed for 30 cycles, which involved denaturation at 94 ˚C for 30 
sec, annealing at 60 ˚C for 30 sec and extension at 72 ˚C for 1 min. The annealing step 
had 1 ˚C increment every cycle for 10 cycles, which would help in better annealing of 
primers over a gradation of temperature. The next amplification step of 20 cycles 
involved denaturation at 94 ˚C for 30 sec, annealing at 65 ˚C for 30 sec, extension at 72 
˚C for 1 min and final extension at 72 ˚C for 5-10 min. 
 
2.2.3 Agarose gel extraction of the PCR products 
The PCR products were analysed on 1% agarose gel for Krm1, Dkk1FL and 
MeCP2 and 1.3% gel for Dkk1Cys2. The agarose gel containing the DNA band of 
interest was cut with a scalpel followed by purification using the Qiaquick Gel Extraction 
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kit (Qiagen) according to standard manufacturer’s protocol. DNA was eluted in 40-50 μl 
of elution buffer. 
 
2.3 CLONING  
2.3.1 pGEM-T-Easy cloning vector 
Ligation of the target DNA after PCR and purification was first carried out into 
the pGEM®-T Easy vector system (Promega) in a 10 µl reaction. The DNA 
concentration of the PCR product was checked using a Nanovue (GE Heathcare) 
spectrophotometer. The following equation was used to calculate the amount of PCR 
product to be used for the ligation reaction. An insert: vector molar ratio of 3:1 was taken 
for the ligation reaction according to manufacturer’s recommendations. 
ng of vector × kb size of insert × insert : vector molar ratio = ng of insert 
          
         kb size of vector        (Eq. 2.1)  
 
1 µl of the vector, 5 µl of 2X ligation buffer and 0.5 µl T4 DNA ligase (Promega) were 
used to set up a ligation reaction. A control for the ligation mixture was prepared in 
another tube without the PCR product. The ligation mixtures were incubated at room 
temperature for 1 hour before being transformed into DH5α competent cells. 
 
2.3.2 Preparation of E. coli DH5α competent cells 
Frozen glycerol stock of DH5α was streaked onto a Luria Bertani (LB) agar plate 
(Sigma) (without ampicillin) and incubated overnight at 37 °C. A fresh single colony was 
inoculated into 5 ml of LB broth and incubated in a shaker overnight at 37 °C. The 
overnight culture was transferred into 100 ml of LB broth and incubated in a shaker at 37 
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°C with shaking speed of 200 rpm. Cells were grown until O.D. at 600 nm wavelength 
reached 0.4 - 0.6 and then transferred into 50 ml tubes and spun at 1,520 g at 4 °C for 10 
min. The supernatant was removed and the cell pellet was resuspended gently with 40 ml 
of cold glycerol buffer (0.1 M CaCl2, 15% glycerol) and then incubated on ice for 30 min. 
Cells were spun at 1,520 g for another 10 min at 4 °C and the supernatant was discarded. 
The pellet was resuspended carefully in 4 ml of cold glycerol buffer, aliquoted at 50 μl 
per tube, frozen in liquid nitrogen and stored at -80 °C. 
 
2.3.3 Transformation into DH5α Competant cells and blue-white screening 
A 50 µl aliquot of the previously prepared competent E. coli DH5α cells was 
thawed on ice for 5 min. 1-5 µl of the plasmid was added, mixed gently and kept on ice 
for 20 min. The cells were then heat shocked at 42 °C for 90 sec and immediately kept 
back on ice for 2 min. 1 ml of LB medium was added into the tube, the cells were 
incubated with shaking at 37 °C for an hour. Cells were microfuged at 9000 rpm for 3 
min and 900 μl of the supernatant was discarded. The cell pellet was resuspended with 
the remaining medium and plated on LB agar plate supplemented with a suitable 
antibiotic for selection. Plates were then incubated overnight at 37 °C. Additionally, for 
blue / white colony screening of colonies with pGEM-T-Easy vector system, 10 µl of 1 
M IPTG and 20 µl of X-gal solution (Biorad) were added to the LB Plates (containing 
appropriate antibiotic) before plating the cells on it. 
 
2.4 SCREENING OF TRANSFORMANTS 
2.4.1 Colony PCR screening  
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The traditional method of colony PCR screening of transformants was used for 
fast screening of ligated transformants. In this method, 10 well separated colonies were 
picked up from the transformant plate and pipeted up and down to resuspend them in 7 μl 
of autoclaved water taken in 10 different tubes. 1 μl of this cell suspension was used as a 
template for doing PCR. A PCR mix was prepared similar to the mix prepared for target 
gene amplification, mentioned in section 2.2 and a PCR protocol unique to each gene 
target for amplification was used. The PCR products were analysed on agarose gel to 
confirm the presence of amplified target inserts at the right gene fragment size. 
 
2.4.2 Double digestion screening 
Proper insertion of a gene into a target plasmid (gene orientation) was then 
verified by double digestion screening of colonies grown on LB-agar plate with suitable 
selection antibiotics. Around 10 colonies (only white colonies in the case of blue white 
screening) were selected for screening from the ligation plate. Usually, the ligation plate 
should have 2-3 fold more colonies as compared to the control plate. The colonies were 
inoculated into 2 ml LB broth containing suitable selection antibiotics and incubated 
overnight with shaking at 37 °C. Cell pellets were recovered by microfuging at 13,000 
rpm for 3 min. DNA plasmid was extracted from pelleted cells by using the Qiagen 
Miniprep kit and eluted with 40 μl of elution buffer. 
A double digestion mixture of 30 μl was set up by taking 3 μl of DNA, purified 
from the colony, 0.5 μl of each of the two restriction enzymes (NEB) whose respective 
sites were present in the upstream and downstream primers of the amplified PCR product 
and 3 μl of the compatible NEB buffer was added. All the 10 tubes were incubated at 37 
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°C for 2.5 - 3 hours. 10 μl of the digestion products were run on 1% agarose gel at 100 V 
to confirm the presence of the respective target insert in the vector. 
 
2.4.3 Agarose gel electrophoresis 
Agarose gel electrophoresis was performed using 1% UltraPure™ agarose 
(Invitrogen) in 60-100 ml 1X Tris-acetate (TAE) running buffer, containing 2 μl of 
ethidium bromide (10 mg/ml) solution. Each DNA sample was first mixed with 2 μl of 
Blue / Orange 6X loading dye (Promega). 3 μl of 1 kb DNA ladder (Promega) was also 
similarly mixed with the dye and loaded alongside the sample wells, serving as a marker 
for estimation of molecular weight. After loading, the gel was run at 90-100 V for about 
an hour until the loading dye reached the end of the gel. DNA bands were then visualised 
using the GeneSnap machine (SynGene BioImaging System) under an ultraviolet (UV) 
transilluminator. Extra care was taken to ensure that all the equipment and reagents used 
for gel electrophoresis were kept separately and gloves were worn at all times to prevent 
toxic EtBr contamination. 
 
2.4.4 Plasmid DNA sequencing 
 
2.4.4.1 Cycle sequencing PCR 
1 μl of plasmid DNA containing about 250 ng of DNA was mixed with 4 μl of 
water, 1 μl of the respective vector specific sequencing primer (3.2 μM), 2 μl of 5X Big 
Dye Buffer and 2 μl of Big Dye Terminator V3.1 (Applied Biosystems). 25 cycles of 
PCR reaction were carried out with the denaturation step at 96 °C for 30 sec, annealing at 
50 °C for 15 sec and extension at 60 °C for 4 min.  
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2.4.4.2 Ethanol precipation 
DNA was then precipitated by adding 1/10th volume of 3 M sodium acetate of pH 
5.2 and mixed by vortexing briefly. Then, 25 μl ice cold 100% ethanol was added to this. 
The mixture was vortexed well and placed in a -80 °C freezer for 15 min before the tubes 
were microfuged at 13000 rpm for 20 min at 4 °C. The supernatant was removed and the 
pellet was washed with 500 μl of 70% ethanol and microfuged at 13000 rpm for 5 min at 
4 °C. The supernatant was carefully aspirated and the sample was dried in a vacuum 
centrifuge before using for sequencing on an automated ABI Prism 3100 (Applied 
Biosystems) Sequencer. 
 
2.5 SUBCLONING INTO EXPRESSION VECTORS  
The sequence verified pGEM-T Easy clones containing the target inserts were 
used for subcloning into expression vectors compatible with bacterial (E. coli), yeast 
(Saccharomyces cerevisiae) and baculovirus (SF9 insect cells) expression. 
 
2.5.1 Subcloning target genes into E. coli and baculovirus vectors 
The target insert was digested from the pGEM-T Easy vector after sequence 
verification, using the respective restriction enzymes flanking its ends. The expression 
vector of interest was also digested with the same set of restriction enzymes. A 50 μl 
double digestion mixture containing 5 μl of the pGEM-T Easy clone [containing the 
target insert (about 50 ng/μl)], 20 U each of the respective restriction enzymes in 5 μl of 
the compatible buffer was set up. The vector was also digested in the same way as the 
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insert and 2 such replica tubes were incubated for 4 - 5 hours at 37 °C. The replica tubes 
were pooled in for insert and vector respectively following incubation. 
To prevent the vector from self-ligating after digestion, it was further subjected to 
de-phosphorylation at the 5´ termini using calf intestinal phosphatase, CIP (NEB). 1 μl of 
CIP was added to 100 μl of the double digested vector and incubated for 1 hour at 37 °C. 
Both the double digested insert and vector were purified to remove all the buffers using 
the PCR Purification kit (Qiagen). DNA was eluted in 40 - 50 μl of elution buffer. 
The above digested products were ligated similar to that of ligation in the pGEM-
T Easy vector with a control reaction. This was followed by transformation of 5 μl 
ligation product into E. coli DH5α cells. The transformed colonies were then screened by 
double digestion and final confirmation was performed by plasmid DNA sequencing. 
 
2.5.2 Subcloning of gene targets into S. cerevisiae  
PTS210 is a yeast expression vector, a YCp50-based construct, containing the 
GAL1/GAL10 promoter, a short polylinker (BamHI, HindIII, XbaI), and the ACT1 
transcriptional terminator (a generous gift from Prof. Davis Ng, Temasek Lifesciences 
Laboratory, Singapore). Gene targets Krm1 and Dkk1 FL were amplified with primers 
having the BamH1 restriction site on both upstream and downstream ends. Blunt end 
ligation was performed by Klenow treatment of the inserts and the vector. After digesting 
the vector and the inserts in a 25 μl reaction using the procedure mentioned in section 
2.4.2 at 37 °C overnight, the vector and insert were subjected to Klenow treatment, 
wherein 0.83 μl of 1 mM dNTPs and 0.2 μl of Klenow (5000 U/ml) was added. The 
mixture was incubated for 15 min at 25 °C and then the samples were subjected to gel 
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extraction and final DNA was eluted in 10 μl elution buffer (Section 2.2.3). The vector 
was then subjected to CIP treatment mentioned in section 2.5.1 followed by heat 
inactivation at 55 °C for 30 min. Phenol / chloroform extraction, followed by ethanol 
precipitation, was performed. 
  
2.5.3 Phenol/ chloroform treatment and ethanol precipitation 
100 μl of phenol / chloroform mixture and 50 μl of dH20 were added to the above 
tube, vortexed well and microfuged at a maximum speed of 13000 rpm for 5 min at room 
temperature. The aqueous phase of about 100 μl was transferred to a fresh tube and the 
interface and the organic phases were discarded. The same steps were repeated again 
from the beginning starting from the addition of phenol/chloroform one more time. After 
this, ethanol precipitation (Section 2.4.4.2) was performed. The DNA pellet was 
resuspended in 10 μl of water. Ligation of vector and insert, transformation, colony PCR 
screening and sequence verification were performed as explained earlier before protein 
expression trials. 
 
2.6 PROTEIN EXPRESSION AND PURIFICATION 
2.6.1 Transformation and small scale expression in E. coli 
The plasmids that contained the gene inserts of Krm1, Dkk1 FL, Dkk1 Cys2 and 
MeCP2 were transformed into several E. coli host strains for expression of recombinant 
proteins. The transformation procedure was carried out as described in section 2.3.3. A 
few of the well separated colonies were picked and inoculated in 2 ml of LB media with 
appropriate antibiotic/s and incubated overnight at 37 °C in a shaker. Next morning, 
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protein expression was tested on small scale (10-50 ml of fresh LB media) containing 
appropriate antibiotic/s for the host strains chosen. LB media was inoculated and grown 
at 37 °C until the cell density reached 0.4 - 0.6 at 600 nm. Induction was then performed 
using varying IPTG concentrations ranging from 0.1 to 1 mM in different tubes and 
protein expression was carried out at 37 °C for 4 - 5 hours and 16 °C for 12-16 hours, 
respectively. The samples were then pelleted down by spinning at 8,983 g for 20 min at 4 
°C. The pellets from 2 ml samples were resuspended in 200 μl of 8 M urea lysis buffer 
and vortexed thoroughly to lyse cells. Samples from whole cell lysate were analysed on 
SDS-PAGE. Samples showing any expression in comparison with the control (uninduced 
and empty vector) were tested for solubility. The cell pellets were resuspended in 2 ml 
lysis buffer (Tris-Cl or 1X PBS) and sonicated at an amplitude of 22% for 10 sec with 
pulse 1 sec on and 1 sec off. Following this, samples were microfuged at 13000 rpm for 3 
min and the supernatant and pellets were analysed separately on SDS-PAGE.  
Table 2.1. Expression trials for proteins. pFastbacHTB is a baculoviral 
vector. PTS210 is a yeast vector (S. cerevisiae). The other vectors 
mentioned in the table are compatible with E. coli. Their pI and Molecular 
weight in kDa are also given. The manufacturer of the vectors are: 
pGEX4T1 (GE Healthcare lifesciences), pET32a, pETduet1 and pET14b 
(Novagen), pFastbacHTB (Invitrogen) and pQE30 (Qiagen). 
 
No. Target  pI/MW (kDa) Expression Vectors used for protein expression 
1 Dkk1FL 8.74 / 29.297 pGEX4T1,  pET32a,  PTS210,  pFastbacHTB 
2 Dkk1 
Cys2 
9.30 / 8.839 pET32a 
3 Krm1 5.62 / 36.487 pQE30, pGEX4T1, pET32a, pETduet1, PTS210, 
pFastbacHTB 
4 Dkk1 FL 
+ Krm1 
 pETDuet1 
5 MeCP2 9.95 / 52.440 pET14b,  pET32a,  pFastbacHTB 
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Dkk1Cys2 and MeCP2, cloned in the pET32a vector, were transformed into the 
E. coli BL21 (DE3) host strain for protein expression in 1 L culture. The expression 
condition for both proteins was at 37 °C, induction with 0.4 and 0.5 mM IPTG, 
respectively with a shaking speed of 200 rpm.  
 
2.6.2 Protein expression in yeast 
2.6.2.1 Transformation in Yeast (W303a, pep4::HIS3 strain)  
About 3 μl of the plasmid DNA (Krm1/Dkk1 FL cloned into the PTS210 vector) 
was taken (about 500 ng) and mixed with 100 μl of PLATE and 2 μl of sonicated salmon 
sperm DNA (Stratagene) of concentration 10 μg/μl. The W303a, pep4::HIS3 strain of 
yeast cells were spread on YPD (Yeast Peptone Dextrose, Sigma) plate and incubated at 
30 °C overnight. The grown cells (only a few) were picked from the plate using toothpick 
and added to the vial containing the PLATE-DNA mixture. The contents were mixed 
well and incubated for 4 hours-overnight at room temperature (about 8 hours is best). The 
contents were then microfuged at 9000 rpm, most of the supernatant was discarded and 
the pellet was resuspended in about 20-30 μl of residual supernatant. This mixture was 
vortexed and then plated on an YPD plate and incubated at 30 °C for 2 days. 
 
2.6.2.2 Preparation of protein for western blotting  
The protein samples expressed in yeast were prepared using the 10% tri-
chloroacetic acid (TCA) cytosolic protein extraction method for western blot analysis. 
Colonies grown on the YPD transformation plate were picked and grown in minimal 
synthetic complete- uracil media to log phase (SC-Ura media with 2% glucose for 
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uninduced control and SC-Ura media with 2% galactose for induced samples). Cells at 
OD600 of 2 units were taken in a 15 ml Falcon tube and microfuged at 1500 rpm for 5 min 
at 4 °C. The pellet was resuspended in 1 ml of 10% TCA on ice. 1 ml of zirconium beads 
(BioSpec) were added on ice and cells were lysed by 2 times 30 sec cycle in mini-bead 
beater at high setting. The lysate was then transferred to a 1.5 ml eppendorf tube. The 
beads were washed with 400 μl of 10% TCA and microfuged at 14000 rpm for 10 min at 
4 °C. The supernatant was discarded by aspiration and the pellet containing the 
precipitated protein was resuspended in 80 μl of TCA resuspension solution (Appendix). 
The contents were boiled for 10 min at 100 °C and vortexed a few times, followed by 
microfuging at 14000 rpm for 15 min at 4 °C. 30 μl of the supernatant was now 
transferred to a new tube and 30 μl of 2X SDS gel loading buffer was added and boiled 
for 10 min at 100 °C. 
 
2.6.2.3 Western blotting 
 Polyvinylidene difluoride (PVDF) membrane, used in western blotting, was first 
soaked in 10 ml of 100% methanol for 10 sec, before washing twice with de-ionised 
water and equilibrated in transfer buffer (48 mM Tris, 39 mM glycine, 20% methanol, 1.3 
mM of 10% SDS). In particular, methanol is necessary for preventing gel expansion by 
heating during the transfer process and to allow the protein to be adsorbed to the 
membrane. The gel, obtained after SDS-PAGE with pre-stained protein ladder markers, 
was then placed on the equilibrated PVDF membrane supported on three layers of filter 
paper pre-soaked in the transfer buffer. This was then overlaid with another three layers 
of pre-soaked filter paper. Care was taken to exclude any air bubbles between the gel, 
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membrane and filter paper to permit proper flow of electric current. Protein transfer was 
then carried out by electrophoresis using Transblot SD, Semidry Transfer Cell (Biorad 
Labs) at 15 mA for 90 min. 
 After the transfer of proteins to the membrane, the membrane with the bound 
proteins was subjected to overnight blocking with 5% milk powder added to PBST (1X 
PBS + 0.05% tween20, a non-ionic detergent used to break unwanted protein-lipid 
interactions) with gentle rocking at 4 °C. This step is critical to prevent non-specific 
binding of immunological reagents to the membrane, hence effectively reducing noise in 
the background of the blot which can lead to false positives. Following blocking, the 
membrane was washed twice for 5 min with 15 ml of PBST. The primary anti-his 
antibody (the protein of interest has a 6X His tag) from mouse was then added for an 
hour to allow for binding to the protein of interest. After that, the membrane was again 
washed with PBST five times for 10 min each to remove any unbound primary antibody 
before the addition of goat anti-mouse IgG secondary antibody. Like before, the 
membrane was washed with PBST thrice for 10 min each, after incubation with the 
secondary antibody for an hour. Subsequently, enhanced chemiluminescent (ECL) 
developing reagents from the SuperSignal®West His Probe™ kit (Pierce) was applied 
evenly on the membrane and exposed to X-ray film, which was then developed and 
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2.7 PROTEIN PURIFICATION 
2.7.1 Using affinity chromatography 
Cells from four liter pellet of Dkk1 Cys2 and two liter pellet of MeCP2 were 
resuspended in 100 ml of lysis buffer [50 mM Tris-HCl (pH 7.0 for Dkk1 Cys2 and pH 
8.5 for MeCP2), 200 mM NaCl, 20 mM imidazole, 5 mM βME] respectively. The cell 
suspension was divided into 25 ml portions and subjected to two cycles of lysis in French 
press (Thermo Electron Corporation) at a cell pressure of 12000 psi followed by 14000 
psi. The suspension after lysis was pelleted for 30 min at 39,391 g at 4 °C. The 
supernatant was collected after lysis and added to five ml bed volume of Talon® Metal 
Affinity Resin (Clontech), pre-equillibrated with the Tris-NaCl lysis buffer. The binding 
of protein to the resin was allowed for one hour at 4 °C on a rocking platform. The 
loosely bound contaminant proteins to the affinity column were removed with three 
washes using wash buffer1 [50 mM Tris-HCl (pH 7.0 for Dkk1 Cys2 and pH 8.5 for 
MeCP2), 200 mM NaCl, 20 mM imidazole, 5 mM βME, 0.5% Tween20] followed by 
additional 2 washes with wash buffer 2 [50 mM Tris-HCl (pH 7.0 for Dkk1 Cys2 and pH 
8.5 for MeCP2), 200 mM NaCl, 40 mM imidazole, 5 mM βME]. His-tagged MeCP2 was 
eluted using elution buffer 1 [50 mM Tris-HCl (pH 8.5), 200 mM NaCl, 250 mM 
imidazole, 5 mM βME] and elution buffer 2 [50 mM Tris-HCl (pH 8.5), 200 mM NaCl, 
400 mM imidazole, 5 mM βME] in a final volume of 10 ml. SDS-PAGE of various 
samples from the process was carried out to confirm the success of the purification step. 
The resin was subjected to regeneration with 20 mM MES buffer (pH 5.0) containing 0.1 
M NaCl followed by five bed volumes of distilled water and stored in 20% ethanol at 4 
°C for further use. 
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2.7.2 Enterokinase cleavage 
 Cleavage of the N-Terminal tags (thioredoxin Trx tagTM, 6X His tag® and S- 
protein affinity containing S tagTM) in the fusion protein of Dkk1 Cys2 in pET32a was 
attempted by protease enterokinase (Roche) cleavage. 25 µg of the fusion protein was 
incubated with 0.6 µg enterokinase according to the standard manufacturer’s protocol. 
The protein was incubated at 4 °C, 16 °C, and at room temperature and 5 μg samples 
were collected at different time points like 1, 3, 6, 12 and 24 hours for analysis using 
SDS-PAGE. 
 
2.7.3 Thrombin cleavage 
Thrombin cleaves only the Trx tag and N-Terminal His tag from the fusion protein, 
but the S-tag (15 aa) is left behind. Thrombin protease (Amersham Biosciences) was 
added at a concentration of 5 U/mg of fusion protein i.e., about 200 units for four liter 
pellet and cleavage was carried out on-column at 4 °C in 10-15 ml of Tris-Cl lysis buffer 
for 20 hours. Majority of the cleaved Dkk1 Cys2 protein was obtained in the flow 
through from the column and a little in the following two washes with the Tris-Cl lysis 
buffer. The Talon purified and cleaved protein still had some amount of contaminant 
proteins, which were visualised by SDS-PAGE analysis. 
 
2.7.4 Gel filtration 
The Trx and N-His tag cleaved protein was further purified by size exclusion 
chromatography on a pre-equilibrated HiLoad 16/60 Superdex-75 column (Amersham 
Biosciences) using the Tris-Cl running buffer [50 mM Tris-HCl (pH 7.0), 200 mM NaCl, 
5 mM βME]. The gel filtration column was pre-equilibrated with at least 1.5 column 
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volumes of running buffer before use. Protein sample was concentrated to about 2.5-3 
mg/ml prior to loading onto the column. Chromatography was carried out with a flow 
rate of 0.7 ml/min and a total buffer volume of 130 ml. Eluted Protein fractions 
corresponding to the protein peak at 280 nm were analysed by SDS-PAGE and pure 
fractions were pooled together and concentrated using 5000 Da MWCO Microcon 
(Millipore) at 755 g  and 4 °C. The concentrated protein was stored at -80 °C until it was 
set up for crystallisation trials. 
 
2.7.5 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
 12.5% / 15% resolving gel and 4% stacking gel were casted according to the 
recipe in Appendix using the Mini-PROTEAN 3 system (Bio-Rad). Protein samples were 
mixed with an equal volume of 2X SDS sample loading buffer and boiled for 5 minutes 
at 100 °C in a heat block. 10 μl of each sample was loaded into the wells, and 
electrophoresis was carried out at 120 V until the marker dye reached the end of the gel. 
The gel was stained with Coomassie blue staining solution for about 20 min and then 
destained using destaining solution (Appendix) overnight. 
 
2.8 BIOPHYSICAL CHARACTERISATION 
2.8.1 Analysis of purity and homogenity 
Concentrated Dkk1 Cys2 protein was analysed for purity and homogeneity by 
SDS-PAGE, Native-PAGE and Dynamic Light Scattering (Dyna Pro from Protein 
Solutions). Peptide Mass fingerprinting was used to confirm the identity of the purified 
protein. 
  
   52  
2.8.2 Circular dichroism 
Circular dichroism (CD) experiments were carried out for Dkk1 Cys2 with 25 μM 
protein in 50 mM Tris-Cl buffer (pH 7.5) at room temperature. The spectra were acquired 
with a J-810 Spectropolarimeter (Jasco, Japan) using a quartz cuvette with 1 mm path 
length (Hellma). The spectra were averaged over 3 scans to reduce the background noise 
and recorded at a wavelength region from 190 nm to 260 nm with 0.1 nm resolutions 
using a scan speed of 50 nm/min and a response time of 8 seconds. 
 
2.9 CRYSTALLISATION TRIALS 
The concentrated Dkk1 Cys2 protein was set up for crystallisation trials using the 
hanging drop vapor diffusion method with different concentrations ranging from 4-8 
mg/ml with Screen 1 and 2 (Hampton Research). The protein was set up under oil for 
crystallisation using microbatch method with the Jena Screen buffers Classic (1-10) in a 
protein: precipitant volume ratio of 1:1. 14 μl of paraffin oil was used to protect the 
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CHAPTER 3: RESULTS AND DISCUSSION 
 
 
3.1 PCR OPTIMISATIONS  
 
For Krm1, PCR optimisation was initially tried with a single step annealing PCR 
protocol using Expand high fidelity PCR System. The forward and reverse primers had 
(BamH1, HindIII) restriction sites respectively. The program contained a denaturation 
step at 95 °C for 3 min, followed by 30 cycles of amplification (denaturation at 94 °C for 
30 sec, annealing at 55 °C for 30 sec and extension at 72 °C for 1 min). This was 
followed by a final extension at 72 °C for 5 min. The above experiment did not yield any 
Krm1 PCR product.  
 The protocol was then modified to incorporate two steps of annealing in order to 
allow the primers to bind more specifically to the target gene. All the other PCR 
conditions were kept constant. A broad range of temperatures were used for each of the 
annealing steps: for the first step, 52-59 °C and for the second step, 55-68 °C 
respectively. This trial again failed to give Krm1 PCR product, however, some non- 
specific primer-dimer formation was observed on agarose gel. 
The high percentage of GC (>60%) in the Krm1 could cause secondary structures, 
which create problems at different stages of the polymerase chain reaction during (1) the 
denaturation of the template (2) annealing of the primer and (3) extension of the primer 
by taq polymerase. Various concentrations of DMSO (1.5 to 5%) were used as an 
adjuvant in the PCR mixture to facilitate DNA strand separation (in GC rich difficult 
secondary structures) because it disrupts base pairing and has been shown to improve 
PCR efficiency. When this experiment also failed to give the Krm1 PCR product, 2X 
ImmoMix™ [ImmolaseTM DNA polymerase, 32 mM (NH4)2 SO4, 134 mM Tris-HCl (pH 
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8.3 at 25 °C), 0.02% Tween 20, 2 mM dNTPs, 3 mM MgCl2] was included in the PCR 
mixture. This polymerase is a heat-activated thermostable DNA polymerase, used mostly 
for T/A cloning and is extremely specific and can eliminate non-specifics such as primer-
dimers and mis-primed products. 
Single step annealing PCR protocol with Immolase DNA Polymerase gave many 
non specific bands as shown in Fig 3.1a. Finally, we could get a single band PCR product 
for Krm1 using a two step gradient PCR, with annealing temperatures optimised at 58 
and 66 °C for the first and second steps, respectively, Fig 3.1b.  
a                                        b  
 
                      
 
Figure 3.1.  PCR optimisations of Krm1 (a) PCR amplification using 2X 
Immomix and single step annealing PCR program. Annealing at 55 °C and 
30 cycles amplification shows many non-specific bands (b) Optimised 
two-step gradient protocol with annealing temperatures at 58 and 66 °C, 
respectively using 2X Immomix gave Krm1 at the right size of 1 kb. 1% 
agarose gel was run.  
 
For the amplification of Dkk1 FL, Dkk1 Cys2 and MeCP2, touchup PCR was 
used. Such a PCR protocol allows for relaxed and specific annealing of primers, which 
gives a better yield of PCR product without swamping of the product of interest by non-
specific amplifications. The earliest steps of a touchdown polymerase chain reaction 
cycle have lower annealing temperatures (58 to 60 °C was used). The annealing 
temperature is increased in increments (of usually 1 °C) for every subsequent set of 
1kb 1kb 
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cycles. Thus, amplification of the above three targets, was quite straightforward using a 
high fidelity Taq polymerase and the templates were full length Dkk1 and MeCP2 in 
pGEM-T-Easy vector.  
                         a                                                   b 
                                         
 
Figure 3.2. Touchup PCR products of MeCP2, Dkk1 FL and Dkk1 Cys2 
(a) 1% agarose gel for MeCP2 (1.46 kb) and Dkk1FL (0.8 kb) (b) 1.3% 
agarose gel for Dkk1Cys2 (0.234 kb).  
 
 
3.2 MOLECULAR CLONING 
 
3.2.1 T/A cloning and blue white screening 
     
All the amplified PCR products were initially cloned into the high copy vector 
pGEM-T-Easy. This is a T/A cloning vector in which single 3´-T overhangs at the 
insertion site of the vector greatly improve the efficiency of ligation of a PCR product 
into the plasmid by preventing re-circularisation of the vector. The Expand high fidelity 
DNA polymerase provides the compatible ‘A’ overhangs for the PCR product. This 
polymerase adds an ‘A’ deoxyadenosine, in a template-independent fashion, to the 3´-
ends of the amplified gene fragments. The constructs thus generated were sequence 
verified using the pairwise alignment algorithm from EBI (European bioinformatics 
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3.2.2 Subcloning of the gene inserts into expression vectors 
The target gene inserts Krm1, Dkk1 FL, Dkk1 Cys2 and MeCP2, after sequence 
verification, were double digested using respective restriction enzymes from the pGEM-
T-Easy vector and then gel extracted. They were subcloned into different expression 
vectors compatible with bacteria (E. coli). Subcloning was also performed into vectors 
compatible for protein expression in yeast (S. cerevisiae) and baculovirus (SF9 insect 
cells), Table 3.1. The vectors contained different types of affinity purification tags, like 
His-tag and GST-tag. All the constructs were double digested with corresponding 
restriction enzymes and completely sequence verified to check for the absence of 
erroneous mutations (frame shift and substitution) in the target gene sequence and for the 
alignment of the target gene in frame with the start codon ATG in the vector. Figs. 3.3, 
3.4 and 3.5 show the double digestion results for the Krm1, Dkk1 FL and MeCP2, 
constructs, respectively.                
            In case of cloning in yeast vector PTS210, blunt end ligation was used because 
several attempts with sticky end ligation using the BamH1 site in the MCS of the vector 
failed. Therefore, Klenow treatment was performed in order to remove both the 5’ and 3’ 
BamH1 sticky overhangs in the vector and inserts (Krm1 and Dkk1 FL). Blunt end 
ligation is advantageous because it is easier for both the vector and insert ends to join 
together due to lack of specificity (unlike in the case of sticky end ligation). However, the 
orientation of the insert may not be in the right direction in the vector. This problem was 
verified by sequencing the positive constructs (confirmed by colony PCR) using PTS210 
vector specific forward and reverse primers. 
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Table 3.1. Target proteins with the corresponding expression systems and 












used for cloning 

















2 Dkk1 FL E. coli pGEX4T1 (4.969 
kb) 
BamH1, Not1 
pET32a (5.9 kb) BamHI, Not1 






3 Dkk1 Cys2 E. coli pET32a (5.9 kb) BamH1, Xho1 
4 Dkk1FL+ 
Krm1 






5 MeCP2 E. coli pET14b (4.671 kb) Nde1, BamH1 
















    
  
   58  
              
                          
 
                                         
 
                                        M      1        2        3       4       5       6      
Figure 3.3. Double digested products of Krm1 constructs. Lanes: M – 1 
kb DNA ladder; 1 – pGEM-T-Easy-Krm1 (digested with BamH1 and 
HindIII); 2 – pQE30-Krm1 (BamH1, HindIII); 3 – pGEX4T1-Krm1 
(BamH1, Not1); 4 – pET32a-Krm1 (BamH1, Xho1); 5 – pETDuet1-Krm1 





                          
                                          
                                              M         1         2         3         4  
 
Figure 3.4.  Double digested products of Dkk1FL constructs.  Lanes: M – 
1 kb DNA ladder; 1 – pET32a-Dkk1FL (digested with BamH1 and Not1); 
2 – pGEX4T1-Dkk1FL (BamH1, Not1); 3 – pGEM-T-Easy-Dkk1FL 
(BamH1, Not1); 4 – pFastbacHTB-Dkk1FL (BamH1, HindIII). 1% 



































   
                                        M       1         2         3         4 
 
Figure 3.5. Double digested products of MeCP2 constructs. Lanes: M – 1 
kb DNA ladder; 1 – pGEM-T-Easy-MeCP2 (digested with BamH1 and 
Xho1); 2 – pET32a-MeCP2 (BamH1, Xho1); 3 – pET14b-MeCP2 (Nde1, 








   M    1   2   3    4    5    6    7    8    
Figure 3.6. Colony PCR products of Krm1 in PTS210. Lanes: M – 1 kb 
DNA ladder; 1-8 – PCR products of 8 colonies picked up for PCR. Lanes 
3, 6, 7 and 8 show positive clones. 1% agarose gel was run. 
 









   60  
    
                                        M     1     2      3     4     5    6    
Figure 3.7. Colony PCR products of Dkk1 FL in PTS210. Lanes: M – 1 
kb DNA ladder; 1-6 – PCR products of 6 colonies picked up for PCR. 
Lanes 3, 4, 5 show positive clones. 1% agarose gel was run. 
 
3.3 PROTEIN EXPRESSION TRIALS 
3.3.1 Expression in E. coli 
Protein expression trials were carried out in E. coli with sequence verified 
constructs made in suitable expression vectors. The conditions that can influence protein 
expression, like host strain, temperature (37, 25 and 16 °C) and IPTG concentration (0.05 
to 1.0 mM) were varied. The results are summarised in Table 3.2.   
The chosen vectors and E. coli host strains are given below.  
For vector pQE30: M15 [pREP4] (Qiagen) and SG13009 [pREP4] (Qiagen). 
For pGEX4T1, pET32a, pET14b and pETDuet1: BL21 (DE3) (Novagen), pLysS 
(DE3) (Novagen), BL21 (DE3) Codon Plus-RP (Stratagene), Rosetta (DE3) 
(Novagen), Origami B (DE3) (Novagen), Rosettagami (DE3) (Novagen), AD494 
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Table 3.2. Summary of protein expression in E. coli, S. cerevisiae and Baculovirus. 
 





1 Dkk1 FL 8.74 / 29.297 pGEX4T1 Nil 
pET32a Nil 
PTS210 Nil 
pFastbacHTB In progress 
2 Dkk1 Cys2 9.30 / 8.839 pET32a Yes, 
Soluble 






pFastbacHTB In progress 
4 Dkk1 FL+Krm1  pETDuet1 Nil 




pFastbacHTB In progress 
 
 
The negative results, Table 3.2, for Krm1 are shown in Fig. 3.8a, 3.8b and 3.8c, 
for Dkk1 FL in Fig. 3.8d and 3.8e and for MeCP2 in Fig. 3.8f. Krm1 in pET32a was 
over-expressed as inclusion bodies, Fig. 3.8c. Trials to recover some soluble protein also 
failed when IPTG concentration was reduced to as low as 0.05 mM and protein 









        
 
                     
                                    M          1     2     3     4          5 
Figure 3.8 (a) Expression of Krm1 in pQE30 vector / M15 cells. Lanes: 
M - Protein Ladder (kDa) ; 1 – sample induced with 0.5 mM IPTG at 37 
°C; 2 – IPTG 1 mM, 37 °C; 3 – IPTG 0.5 mM, 16 °C; 4 – IPTG 1 mM, 16 





           
                                       M       1          2           3         4               
Figure 3.8 (b) Expression of Krm1 in pGEX 4T1 vector / BL21 (DE3) 
cells. Lanes: M - Protein ladder (kDa) ; 1 -  sample induced with 1 mM 
IPTG at 37 °C; 2 – IPTG 0.5 mM, 37 °C; 3 – uninduced control; 4 – 
induced control of pGEX 4T1 empty vector.  
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   1         2       M      3       4        5        6 
Figure 3.8 (c) Expression of Krm1 in pET32a vector / BL21 (DE3) cells. 
Lanes: 1 – uninduced supernatant ; 2 – uninduced pellet ; M -  Protein 
ladder (kDa); 3 – supernatent induced with 0.5 mM IPTG at 37 °C ; 4 – 
pellet induced with 0.5 mM IPTG, 37 °C ; 5 – supernatent induced with 





                                     M               1        2         3       4  
Figure 3.8 (d) Expression of Dkk1 FL in pGEX4T1 vector / BL21 (DE3) 
cells. Lanes: M – Protein Ladder (kDa); 1 – sample  induced with 1 mM 
IPTG, 37 °C ; 2 –  IPTG 0.5 mM, 37 °C; 3 – uninduced control; 4 – 
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 M      1           2              3        4         5 
Figure 3.8 (e) Expression of Dkk1 FL in pET32a vector / BL21 (DE3) 
cells. Lanes: M – Protein Ladder (kDa); 1 – uninduced control; 2 – sample 
induced with 1 mM IPTG, 37 °C; 3 – uninduced control; 4 – IPTG 0.5 




                                     M      1         2        3       4      5 
Figure 3.8 (f) Expression of MeCP2 in pET14b vector / pLySS (DE3) 
cells. Lanes: M - Protein Ladder (kDa);  1 –  supernatant induced with 0.5 
mM IPTG, 16 °C; 2 – supernatent induced with 0.5 mM IPTG, 37 °C ; 3 – 
pellet induced with 0.5 mM IPTG, 16 °C ; 4 – pellet induced with  0.5 mM 
IPTG, 37 °C;  5 – uninduced control. 
                           
Protein expression for both Krm1 and Dkk1 FL was tested in S. cerevisiae strain              



































                                       C        UK     IK      UD      ID 
 
Figure 3.9. Western blot analysis of Krm1 and Dkk1FL using anti-his 
primary antibody. Lanes are marked as: C – Alpha-his protein as control 
expressed at 95 kDa; UK– uninduced Krm1 control; IK - induced Krm1 
sample ; UD – uninduced  Dkk1FL control; ID – induced Dkk1FL sample.   
Krm1 and Dkk1 FL show no expression in the induced samples at the 
expected size of 36 kDa and 29 kDa respectively when compared with 
their respective uninduced controls. 
 
 
From the above results, we learn that Krm1, Dkk1 FL could not be expressed in both E. 
coli and S. cerevisiae.  
 
3.4 REASONS FOR PROTEIN EXPRESSION FAILURE AND REMEDIES 
There are several reasons behind the failure of protein expression in E. coli. Some 
of them are discussed below. 
Toxic gene expression and additional plasmid stability: Even in the absence of 
IPTG, there is some expression of T7 RNA polymerase from the lacUV5 promoter in 
λDE3 lysogens and therefore, basal expression of the target protein. Any recombinant 
protein expressed in E. coli may interfere with normal cell function and therefore may be 
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gene products are sufficiently toxic to E. coli, this basal level of expression can be 
enough to prevent vigorous growth and the establishment of plasmids in λDE3 lysogens. 
The proteins Krm1 and Dkk1 FL may be toxic to the host cell when expressed. However, 
one approach to control basal expression is to use vectors that contain a T7 lac promoter 
eg: pET32a vector (pET System Manual, Novagen). 
  For very high toxic genes, a combination of T7 Lac promoter-containing vector 
and pLysS is preferable. Usage of pLysS (DE3) hosts confers additional stability to the 
plasmid because the host strain contains a compatible plasmid that provides small amount 
of T7 lysozyme, a natural inhibitor of the T7 RNA polymerase (pET System Manual, 
Novagen).  Thus, we made use of this host strain in our expression trials. 
 Solubility issues: The Bioinformatical analysis of Krm1 showed that it has ~80% 
and Dkk1 FL has 93% chance of insolubility, respectively when expressed in E. coli.  
Protein solubility was presumably improved in our experiments by using the pET32a 
vector, which produces a thioredoxin fusion protein. The N-terminal thioredoxin tag 
promotes disulfide bond formation and thereby, increases the yield of soluble product in 
the cytoplasm (pET System Manual, Novagen). Krm1 has 16 cysteine residues and 24 
proline residues, Dkk1 FL has 22 cysteines, 17 arginines and 14 prolines. The presence of 
such a high number of these amino acids may confer difficulty in protein expression. 
Additionally, the thioredoxin-reductase deficient strain AD494 (DE3) was used to 
maximise soluble target protein expression. The trxB- cells have been shown to permit 
disulfide bond formation in the cytoplasm of E. coli, which appears to depend on the 
presence of an oxidised form of thioredoxin (pET system manual, Novagen). 
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Rare codon problem: The Krm1, Dkk1 FL and MeCP2 proteins contain around 4-
6 arginines. However, there are not many arginines in the amino terminus of the proteins 
which would otherwise cause a severe problem (pET system manual, Novagen). The 
usage of E. coli strains like BL21-Codon plus (DE3) RP and BL21 (DE3) Rosettagami 
normally takes care of eukaryotic protein expression, by supplying tRNAs for rare 
codons. 
 
3.4.1 Co-expression of proteins 
Co-expression of two or more interacting proteins is a strategy that is occasionally 
employed to increase the yield and solubility of them. Many proteins are only active as 
heteromeric complexes and in cases where one protein is unstable without the other, co-
expression would be an ideal method of choice. The authenticity of biological complex of 
Krm1-Dkk1 FL logically allowed our attempt to express these two proteins 
simultaneously in the pETDuet1 vector. However, no expression of Krm1 or Dkk1 FL 
was detected in pETDuet1 expression. 
Residues 1-20 and 390-409 of Krm1 is more hydrophobic, Fig. 3.10. However, 
we used only the fragment containing 21-350 aa for our studies. Krm1 may have a natural 
tendency to form inclusion bodies when expressed in bacteria. This is also one of the 
resons why we attempted to express Krm1 along with Dkk1.  
 
3.4.2 Expression in yeast (S. cerevisiae) 
Over-expression of proteins in yeast has a unique advantage. Being a higher order 
eukaryotic system, yeast can aid a protein in proper folding and post-translational 
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modification. These single-celled eukaryotic organisms grow quickly in defined medium, 
are easier and less expensive to work with than insect or mammalian cells, and are easily 
adapted to fermentation. Yeast expression systems are ideally suited for large-scale 
production of recombinant eukaryotic proteins. But, trials of Krm1 and Dkk1 FL 









Figure 3.10. The Kyte-Doolittle hydropathy plot for Kremen1 (473 aa). 
The peak region above 1.8 (red line) is a transmembrane region. 
 
 
3.5 EXPRESSION AND PURIFICATION OF HIS-TAGGED Dkk1Cys2 
      The expression of Dkk1 Cys2 was successful with pET32a vector. Dkk1 Cys2 
was initially expressed in E. coli BL21 (DE3) cells in small scale using 50 ml LB to test 
the expression level and its solubility at 37 °C and 0.4 mM IPTG. The protein was 
soluble, Fig. 3.11. 
This was followed by large scale, 4 L culture of LB, supplemented with ampicillin. Cells 
were harvested and lysed using French press and centrifuged to separate supernatant from 
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cell debris. The supernatant was loaded into a Talon affinity column as a first step of 
purification of His tagged Dkk1 Cys2. After giving sufficient wash to the column with 
wash buffers, Dkk1 Cys2 was separated from other bacterial proteins that were bound 
non-specifically to the column. After several unsuccessful cleavage attempts to release 
the protein from the tag / bead with enterokinase, the protein was cleaved with thrombin 
and was eluted out in a final volume of 20 ml. Eluted fractions were checked by SDS-
Page, Fig. 3.12. 
However, digestion by thrombin could not remove the S-tag from the protein. 
Hence, all the work carried out was with the protein containing S-tag. The elutions were 
concentrated to 2-3 mg/ml before loading into a Sephadex-75 gel-filtration FPLC column 
for further purification. The monomeric protein was eluted out at an elution volume of 
about 80 ml as a single peak (Fig. 3.13).  
 
     
                                                  M        U          S         P 
 
Figure 3.11. Small Scale expression of Dkk1Cys2. Lanes: M - protein 
ladder (kDa) ; U - uninduced; S - supernatent; P - pellet. Dkk1 Cys2 is 
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                              S       FT     W1      W2   RB   RA    E1     E2       M 
Figure 3.12. Talon affinity purification of His-tagged Dkk1Cys2. Lanes: 
S - supernatent; FT - flow through; W1, W2 - initial and final washes; RB 
- Beads with bound Dkk1Cys2 before thrombin cleavage; RA - beads with 
the Trx-His tag after thrombin cleavage; E1, E2 - elutions 1 and 2 from the 
column after cleavage; M - protein ladder (kDa). It can be seen that most 
of the contaminating bacterial proteins are removed in the elution lanes.  
 
 
                                                                                        B9       B2  
Figure 3.13. Gel filtration profile of Dkk1Cys2 on a Sephadex-75 column. 
Fractions B9-B2 under the peak was pooled for further characterisations. 
 
The purity of the protein was improved and appeared as a single band at a 
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                           M     B2     B3    B4    B5     B6     B7    B8    B9 
           
Figure 3.14. 15% SDS gel of the thrombin cleaved Dkk1 Cys2. The lanes 




3.6 ANALYSIS OF PROTEIN PURITY, HOMOGENITY AND MOLECULAR 
WEIGHT 
Dkk1 Cys2 was purified to at least 98% pure as analysed by SDS-PAGE. The 
homogeneity of the protein was analysed using Dynamic Light Scattering (DLS) and 
native-PAGE. 
The DLS results, Fig. 3.15, suggest that the protein is mono-disperse with a good 
poly-dispersity index of less than 20% at concentrations less than 5 mg/ml, which is 
suited for crystallisation trials. However, the molecular weight appears to be quite high of 
about 62 kDa on DLS after concentrating the protein to 8.5 mg/ml instead of 12 kDa, 
after thrombin cleavage. This suggests that the protein may be an oligomer or it is also 
possible that the molecule may not be assuming a spherical shape for accurate size 
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Figure 3.15. Dynamic Light Scattering analysis of Dkk1 Cys2 at a 
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Therefore, DLS by itself may not be a very accurate technique in determining the 
homogenous state of some proteins. A native gel, Fig. 3.16, was run to confirm the 
physical state of the protein to be a monomer which was used for crystallisation trials. 
                  
Figure 3.16. Native gel of Dkk1Cys2 at a concentration of 5.5 mg/ml 
shows that the protein is a monomer. 
 
3.7 CIRCULAR DICROISM OF Dkk1Cys2 
A negative peak at 218 nm and a positive peak around 196 nm were observed in 
the CD spectrum of Dkk1 Cys2, Fig. 3.17. These two peaks are characteristic of a β-sheet 
structure. However, there is also another minimum at 210 nm, which may be due to a 
possible lower percentage of α-helical structure. The spectrum generated is 
 
             Figure 3.17. CD Spectrum of Dkk1 Cys2. 
Buffer used: 50mM tris-Nacl 
buffer, pH7.5  
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quite consistent with the secondary structure prediction of Dkk1 Cys2, Fig. 3.18. But the 
prediction result shows that a major portion of Dkk1 Cys2 is random coil which is not 
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Figure 3.18.  Predicted secondary structure of Dkk1 Cys2. H-helix, E-
strand and C-coil. 
 
3.8 PEPTIDE MASS FINGERPRINTING (PMF) 
The molecular weight of Krm1 ~ 53 kDa with an 18 kDa Trx-tag. The source for 
the PMF result, Fig. 3.19, turns out to be of Rattus norvegicus, which is not correct. This 
may have occurred because of the presence of impurities after denaturing and purification 





Figure 3.19. Peptide mass fingerprinting of Krm1 with the thioredoxin tag 
shows to be Krm-1 from Rattus norvegicus. The probability based Mowse 
score from the Mascot search of Krm1 shows a hit with gi 16758464. 
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The molecular weight seen from the result for Dkk1 Cys2, Fig. 3.20, is ~30 kDa 
with ~18 kDa accounting for the Trx-tag and the remaining 12 kDa is accounted for 




Figure 3.20. Peptide mass fingerprinting of Dkk1 Cys2 with a 
thioredoxin tag is confirmed to be Dkk-1 from Mus musculus. The 
probability based Mowse score from the Mascot search of Dkk1 Cys2 
shows a hit with gi 31542557.  
   
 
3.9       EXPRESSION AND PARTIAL PURIFICATION OF MeCP2 
 
MeCP2 cloned into pET32a vector was expressed in BL21 (DE3) cells, Fig 3.21. 
The protein expression was observed at 37 °C and 0.5 mM IPTG.  The protein was quite 
soluble, Fig 3.22. This was followed by large scale, 2 L culture of LB, supplemented with 
ampicillin. Cells were harvested and lysed using French press and centrifuged to separate 
supernatant from cell debris. The supernatant was loaded into a Talon affinity column as 
a first step of purification of His tagged MeCP2. Sufficient washes were given to the 
column with wash buffers and MeCP2 was eluted out in a final volume of 10 ml.  Eluted 
fractions were checked by SDS-PAGE, Fig. 3.23. 
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                                      M      1         2           3         4      
Figure 3.21. Expression of MeCP2 in pET32a vector / BL21 (DE3) cells. 
Lanes: M – Protein Ladder (kDa); 1 – induced control of empty pET32a 
vector; 2 -  uninduced control ; 3 –  sample induced with 0.5 mM IPTG, 













                                              U       M      P         S                                  
 
Figure 3.22. Solubility check of MeCP2. Lanes: U – uninduced control ; 
M- protein ladder (kDa) ; P – pellet ; S - supernatent. MeCP2 is quite 
soluble. 
 
The eluted protein from His-tagged affinity column was then loaded into a Sephadex-200 
gel-filtration FPLC column for further purification, Fig 3.24. A single protein peak was 







































                                     M    S   FT  W1  W2   E1   E2   E3    E4 
 
Figure 3.23. Talon affinity purification of His-tagged MeCP2. Lanes : M - 
protein ladder (kDa) ; S - supernatent; FT - flow through; W1, W2 - initial 
and final washes;  E1, E2 - elutions 1 and 2  using elution buffer 1;  E3, E4 









                             
 
 
Figure 3.24. Gel filtration profile of His-tagged MeCP2 on Sephadex- 200 
gel filtration column.  
 
The protein MeCP2 was visualised on the SDS-PAGE at ~97 kDa with the Trx tag which 
is 18 kDa. But, the actual size of the protein should be 53 kDa. The big difference is the 
size of ~26 kDa may be due to stable association of the protein with co-factors like Sin3a, 
Dnmt1, CoREST, SUV39H1 or C-SKI. Additionally, it may also be possible that the 
protein may be forming a homo-multimer due to self-association. 

















                                             M               A12  A13  A14   A15 
Figure 3.25. 12.5% SDS-PAGE analysis of his-tagged MeCP2 elution 
fractions under the gel-filtration peak, A12-A15.  Lane M: Protein ladder 
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CHAPTER 4: CONCLUSIONS AND FUTURE WORK 
 
In the projects undertaken, we aimed to determine the crystal structures of three 
proteins, Kremen1, Dickkopf1 and MeCP2 which are crucial players in mammalian 
development.  
We have expressed and purified the Cys2 domain of Dkk1 from Mus musculus, 
which has been proved to be necessary and sufficient in binding with Krm1.  
The C-terminal domain of Dkk1 from Mus musculus, Dkk1 Cys2 has been cloned 
in pET32a vector and over-expressed in E. coli BL21 (DE3) strain. The protein has been 
purified by affinity chromatography and gel filtration. The protein is quite homogenous 
as indicated by dynamic light scattering studies and Native-PAGE. The secondary 
structure from Circular Dichroism analysis confirms the proposed model that Dkk1 Cys2 
is similar to Colipase, which is made up of only β-strands. Dkk1 Cys2 has been 
concentrated up to 8 mg/ml and has been set up for crystallisation using several screens. 
Once protein crystal formation is observed, we would proceed with condition 
optimisations to get crystals of diffraction quality. Additionally, NMR studies could also 
be performed to solve the protein structure in solution. 
Krm1 from Mus musculus was cloned into several E. coli vectors. The pET32a 
vector containing the thioredoxin solubility fusion tag could express the protein only in 
inclusion bodies in E. coli. Several attempts for expression, including Dkk1 FL+Krm1 
co-expression to get some soluble protein in E. coli failed. Expression in higher 
eukaryotic expression system, like S. cerevisiae, was also attempted for the Krm1 and 
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Dkk1 FL proteins, but, unfortunately no protein expression was detected even in 
inclusion bodies.  
MeCP2 from Homo sapiens was cloned into E. coli vectors and some soluble 
protein expression has been observed in the initial small scale trials. The protein has been 
purified by affinity chromatography and gel filtration. However, biophysical 
characterisation of the protein has to be performed in order to analyse the molecular size, 
homogeneity and secondary structure of MeCP2. A molecular size discrepancy of ~26 
kDa has been observed on the SDS-PAGE gel (97 kDa containing 18 kDa Trx tag) when 
compared to the expected size of the protein (53 kDa). This discrepancy could be 
interpreted by analysis of the purified protein by mass-spectrometry and peptide mass 
fingerprinting to find out possible stable association of MeCP2 with any co-factors. The 
homogenity of the protein and secondary structure could be checked using DLS / Native-
PAGE and Circular Dichroism, respectively. 
The suitability of baculovirus system for eukaryotic protein expression may 
permit us to overcome the failure of expression of soluble Krm1, Dkk1 FL and MeCP2. 
The key features associated with this system could be an advantage to us at this stage. 
This includes suitability of protein expression from mammalian source and ease of post 
translational modification, cytotoxic protein expression and also faster and easier scale up 
to larger volumes in case of detectable soluble proteins. 
At the same time two other options can be explored for expression of Krm1 and 
Dkk1 FL which contain a high number of cysteine residues. They are: 
 
1.  Periplasmic protein Expression 
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In contrast to the cytoplasm, the periplasm of E.coli has an oxidising environment 
that contains enzymes to catalyse the formation and isomerisation of disulfide bonds. 
Directing heterologous proteins to the periplasm using a suitable signal sequence can be 
one of the strategies when attempting to isolate active and properly folded proteins 
containing disulfide bonds. 
 
2.  Solubilisation of inclusion bodies  
Krm1 can be purified under denaturing conditions of urea or guanidium 
hydrochloride or using a detergent like Tween 20 followed by refolding. This method is 
not highly recommended as it could distort the secondary structure of the protein in the 
process. 
 
3.  Artificial gene synthesis 
Krm1 and Dkk1 FL could be fused together using synthetic gene synthesis for 
production of their complex. Gene synthesis aids in codon usage optimisation and 
optimal expression of the proteins in a heterologous expression system. 
Recently, constructs for Krm1, Dkk1 FL and MeCP2 have been made in the 
pFastbacHTB vector for expression in baculovirus. Additionally, trials can be made for 
co-expression of Dkk1 FL-Krm1 in baculovirus. Also, for MeCP2, whose domains have 
been characterised, the TRD domain has been mapped to play a significant role in 
transcriptional repression. The domain structure is definitely of interest, which could be 
attempted for as a future work in addition to solving the structure of full-length MeCP2. 
Cloning of the TRD domain in pET32a vector has already been initiated. 
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     40%  PEG 3350 (autoclaved)  
        100 mM LiOAc (filtered)  
        10X TE pH 7.5 [10 mM Tris-HCl (pH 7.5) ; 1 mM EDTA (pH 8.0)] 
 
TCA resuspension solution 
  3 % SDS 
   100 mM Tris-HCl (pH 11.0) 
   3 mM DTT 
        
Coomassie staining solution 
  0.1% Coomassie brilliant blue R-250 
  40% Ethanol 
  10% Acetic acid 
  Coomassie is dissolved in ethanol before adding water and acetic acid. 
 
Destaining solution 
 10% acetic acid 
 
SDS-PAGE gel composition 
 
 Resolving gel composition: 
 12.5% gel: 
            For 5 ml buffer, 1.3 ml 1.5 M Tris pH 8.8, 2 ml 30% acrylamide, 0.05 ml 10% 
SDS, 0.05 ml 10% APS and 0.002 ml TEMED are added. 
 
 15% gel:  
For 5 ml buffer, 1.3 ml 1.5 M Tris pH 8.8, 2.5 ml 30% acrylamide, 0.05 ml 10% 
SDS, 0.05 ml 10% APS and 0.002 ml TEMED are added. 
      
 Stacking gel composition:  
4% Gel:  
For 2 ml buffer, 0.25 ml 1.0 M Tris pH 6.8, 0.33 ml 30% acrylamide, 0.02 ml 
10% SDS, 0.02 ml 10% APS and 0.002 ml TEMED are added. 
 
For native gels, the composition is the same as SDS-PAGE gel, only addition of 
SDS to the buffers is excluded. 
 
2 X SDS gel loading buffer 
100 mM Tris-HCl (pH 6.8) 
 200 mM DTT 
 4% SDS 
 20% glycerol 
 0.2% bromophenol blue 
  
   
 
 
 
 
 
 
 
 
